Materiały źródłowe

• #1 Postural Tachycardia Syndrome (POTS) Diagnosis and Treatment: Basics and New Developments

  https://www.acc.org/Latest-in-Cardiology/Articles/2016/01/25/14/01/Postural-Tachycardia-Syndrome-POTS-Diagnosis-and-Treatment-Basics-and-New-Developments

  POTS is defined as the presence of chronic symptoms of orthostatic intolerance (6 months) accompanied by an increased heart rate (HR) 30 bpm within 10 minutes of assuming an upright posture and in the absence of orthostatic hypotension (blood pressure [BP] fall 20/10 mmHg). […] Treatment efforts should begin by correcting reversible causes and optimizing chronic disease management. Patient education is important. If there has been a bout of prolonged bed rest, symptoms should gradually improve as patients recondition themselves to upright posture. POTS patients should avoid aggravating factors such as dehydration, and extreme heat. In an effort to optimize hydration, we patients are asked to consume 8-10 cups of water daily and to increase their sodium intake to up to 8-10 g/day. This should ideally be accomplished by dietary modification. We recommend panty-hose (waist high) style compression stockings with 30-40 mmHg of counter-pressure to minimize peripheral venous pooling and to enhance venous return. Elevating the head of the bed up on blocks 4-6 inches may also be helpful to facilitate expansion of the plasma volume.

• #2 Dysautonomia International: Postural Orthostatic Tachycardia Syndrome

  https://www.dysautonomiainternational.org/page.php?ID=30

  If an underlying cause of the POTS symptoms can be identified, treating the underlying cause is very important as well. […] Currently, there is no cure for POTS, however researchers believe that some patients will see an improvement in symptoms over time. […] With proper lifestyle adjustments, exercise, diet and medical treatments, many patients see an improvement in their quality of life. […] If an underlying cause can be identified, and if that cause is treatable, the POTS symptoms may subside.

• #3 POTS: Causes, Symptoms, Diagnosis & Treatment

  https://my.clevelandclinic.org/health/diseases/16560-postural-orthostatic-tachycardia-syndrome-pots

  Postural orthostatic tachycardia syndrome (POTS) is a condition that causes a number of symptoms when you transition from lying down to standing up, such as a fast heart rate, dizziness and fatigue. While theres no cure, several treatments and lifestyle changes can help manage the symptoms of POTS. […] Unfortunately, theres no cure for POTS. Instead, healthcare providers use several strategies to manage the symptoms of POTS. Treatment is highly individualized based on your symptoms and what works best for you. […] The main forms of treatment include: Exercise and physical activity. Diet and nutrition. […] Medical compression stockings can also help push blood up from your legs to reduce POTS symptoms. […] Exercise and physical activity are key to managing POTS. […] Studies show that reclined aerobic exercise, such as swimming, rowing and recumbent bicycling, has the best results. Strengthening your core and leg muscles is also helpful.

• #4 POTS-associated Conditions and Management Strategies | USC Journal

  https://www.uscjournal.com/articles/narrative-review-postural-orthostatic-tachycardia-syndrome-associated-conditions-and?language_content_entity=en

  Postural orthostatic tachycardia syndrome (POTS) is a heterogeneous disorder that presents with positional tachycardia and a constellation of other symptoms. Peer-reviewed evidence for treatment options is limited. […] Treatment regimens are extremely patient specific and primarily focus on symptom improvement and gradual exercise tolerance. […] There are various therapies available for the management of POTS. Although some of these therapies are recommended based on peer-reviewed evidence, there are additional medications that have been anecdotally found to be effective. […] Special care should also be taken to not only treat POTS symptoms, but also to treat the potential underlying cause or associated condition the patient presents with. […] Non-pharmacologic Therapies […] Exercise, increased salt (10-12 g/day) and fluid intake (2-3 l/day), and discontinuing medications that may contribute to POTS should be initiated in all patients diagnosed with POTS.

• #5 Postural Orthostatic Tachycardia Syndrome – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK541074/

  Postural orthostatic tachycardia syndrome is a condition where an unusually significant increase in heart rate accompanies the action of an individual going from lying to standing. […] Describe the treatment modalities indicated for postural orthostatic tachycardia syndrome. […] The management of postural orthostatic tachycardia syndrome is divided into non-pharmacologic and pharmacologic approaches and is contingent on accurate diagnosis, patient education, and therapy adherence. […] Patient education and management of expectations are crucial to the overall successful management of POTS, given its often non-specific and chronic debilitating nature. […] Exercise conditioning is a fundamental aspect of postural orthostatic tachycardia syndrome treatment (class IIA), and it is a recommendation for all patients to start on a gradual physical exercise regimen.

• #6 Dysautonomia International: Postural Orthostatic Tachycardia Syndrome

  https://www.dysautonomiainternational.org/page.php?ID=30

  Postural orthostatic tachycardia syndrome (POTS) is a common autonomic nervous system disorder characterized by an excessively fast heart rate and symptoms of lightheadedness upon standing. […] Each patient is different, thus consulting with a physician who has experience in treating autonomic disorders is important. The most common treatments for POTS include increasing fluid intake to 2-3 liters per day; increasing salt consumption to 8,000 mg to 10,000 mg per day; wearing compression stockings; raising the head of the bed (to conserve blood volume); reclined exercises such as rowing, recumbent bicycling and swimming; a healthy diet; avoiding substances and situations that worsen orthostatic symptoms; and finally, the addition of medications meant to improve symptoms. […] Many different medications are used to treat POTS, such as Fludrocortisone, Beta Blockers, Midodrine, Clonidine, Pyridostigmine, Benzodiazepines, SSRIs, SNRIs, Erythropoietin and Octreotide.

• #7 Postural Orthostatic Tachycardia Syndrome – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK541074/

  Postural orthostatic tachycardia syndrome is a condition where an unusually significant increase in heart rate accompanies the action of an individual going from lying to standing. […] Describe the treatment modalities indicated for postural orthostatic tachycardia syndrome. […] The management of postural orthostatic tachycardia syndrome is divided into non-pharmacologic and pharmacologic approaches and is contingent on accurate diagnosis, patient education, and therapy adherence. […] Patient education and management of expectations are crucial to the overall successful management of POTS, given its often non-specific and chronic debilitating nature. […] Exercise conditioning is a fundamental aspect of postural orthostatic tachycardia syndrome treatment (class IIA), and it is a recommendation for all patients to start on a gradual physical exercise regimen.

• #8 POTS Program | Lurie Children’s

  https://www.luriechildrens.org/en/specialties-conditions/pots-program/

  Postural Orthostatic Tachycardia Syndrome or POTS is a clinical syndrome of orthostatic intolerance characterized by a sustained and marked increase in heart rate with little to no change in blood pressure during position changes, plus chronic symptoms of orthostatic intolerance. […] The POTS Program within Cardiology at Lurie Childrens provides comprehensive care to patients with cardiovascular symptoms of POTS. […] In our POTS Program, the primary goals of management are to reduce postural symptoms and enhance overall quality of life. Initial management of symptoms includes non-pharmacologic strategies as a first line of therapy including improved hydration, daily exercise, optimization of nutrition, and withdrawal of medications that can exacerbate orthostatic tachycardia. […] Many pediatric POTS patients avoid exercise altogether due to symptom exacerbation during and following activity. To address this, our POTS team has incorporated a clinical exercise physiologist (CEP) into all of our POTS clinics to highlight the benefit of symptom management with a daily exercise program.

• #9 Management of Postural Orthostatic Tachycardia Syndrome in the Absence of Randomized Controlled Trials

  https://www.innovationsincrm.com/cardiac-rhythm-management/articles-2021/july/1785-management-of-postural-orthostatic-tachycardia-syndrome

  Postural orthostatic tachycardia syndrome (POTS) is a clinical syndrome causing patients to experience light-headedness, palpitations, tremors, and breathlessness upon assuming an upright posture. […] This article aims to provide a starting point in the form of a review that discusses the different treatment modalities, the known mechanisms of actions, and the indications for use for each treatment modality. […] The management of POTS can be divided into non-pharmacologic and pharmacologic categories. […] Nonpharmacologic management options are first-line therapies. […] A common symptom of POTS patients includes the sensation of breathlessness when standing. […] Some of the symptoms observed in POTS overlap with exercise deconditioning. […] In patients with hypovolemic POTS, management is centered around maintaining adequate intravascular volume.

• #10 POTS-associated Conditions and Management Strategies | USC Journal

  https://www.uscjournal.com/articles/narrative-review-postural-orthostatic-tachycardia-syndrome-associated-conditions-and?language_content_entity=en

  Compression stockings are useful for decreasing lower extremity blood pooling and increasing venous return, although the stockings should reach at least the thigh for maximum benefit. […] Dietary changes can significantly improve the quality of life of POTS patients. […] Pharmacologic Therapies […] Currently, there are no Food and Drug Administration (FDA)-approved treatments for POTS, and pharmacologic agents used in POTS patients are considered off-label. […] Medications That Target Vascular Tone […] Midodrine, an α1-adrenergic agonist, is an effective treatment for POTS secondary to abnormal vascular tone by increasing vasoconstriction and, consequently, improving venous return to the heart. […] Medications That Target Rapid Heart Rate […] β-blockers are frequently used for tachycardia in POTS patients.

• #11 POTS: Causes, Symptoms, Diagnosis & Treatment

  https://my.clevelandclinic.org/health/diseases/16560-postural-orthostatic-tachycardia-syndrome-pots

  Managing diet and nutrition is another important aspect of managing POTS symptoms. […] If you have the hypovolemic (low blood volume) form of POTS, your healthcare provider will likely recommend increasing both your fluid and salt intake to increase blood volume. […] The U.S. Food and Drug Administration (FDA) hasnt approved any medications for POTS treatment. But healthcare providers sometimes prescribe medications off-label to help certain POTS symptoms. […] These medications include: Fludrocortisone (increases salt retention and blood volume). Pyridostigmine (may reduce tachycardia). Midodrine (causes widespread vasoconstriction). Beta-blockers (may reduce upright tachycardia). […] Aside from exercise and dietary changes, other things you can do to manage POTS include frequently monitoring your pulse and blood pressure and getting quality sleep.

• #12 POTS-associated Conditions and Management Strategies | USC Journal

  https://www.uscjournal.com/articles/narrative-review-postural-orthostatic-tachycardia-syndrome-associated-conditions-and?language_content_entity=en

  Postural orthostatic tachycardia syndrome (POTS) is a heterogeneous disorder that presents with positional tachycardia and a constellation of other symptoms. Peer-reviewed evidence for treatment options is limited. […] Treatment regimens are extremely patient specific and primarily focus on symptom improvement and gradual exercise tolerance. […] There are various therapies available for the management of POTS. Although some of these therapies are recommended based on peer-reviewed evidence, there are additional medications that have been anecdotally found to be effective. […] Special care should also be taken to not only treat POTS symptoms, but also to treat the potential underlying cause or associated condition the patient presents with. […] Non-pharmacologic Therapies […] Exercise, increased salt (10-12 g/day) and fluid intake (2-3 l/day), and discontinuing medications that may contribute to POTS should be initiated in all patients diagnosed with POTS.

• #13 Postural Orthostatic Tachycardia Syndrome – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK541074/

  Postural orthostatic tachycardia syndrome is a condition where an unusually significant increase in heart rate accompanies the action of an individual going from lying to standing. […] Describe the treatment modalities indicated for postural orthostatic tachycardia syndrome. […] The management of postural orthostatic tachycardia syndrome is divided into non-pharmacologic and pharmacologic approaches and is contingent on accurate diagnosis, patient education, and therapy adherence. […] Patient education and management of expectations are crucial to the overall successful management of POTS, given its often non-specific and chronic debilitating nature. […] Exercise conditioning is a fundamental aspect of postural orthostatic tachycardia syndrome treatment (class IIA), and it is a recommendation for all patients to start on a gradual physical exercise regimen.

• #14 POTS: Causes, Symptoms, Diagnosis & Treatment

  https://my.clevelandclinic.org/health/diseases/16560-postural-orthostatic-tachycardia-syndrome-pots

  Managing diet and nutrition is another important aspect of managing POTS symptoms. […] If you have the hypovolemic (low blood volume) form of POTS, your healthcare provider will likely recommend increasing both your fluid and salt intake to increase blood volume. […] The U.S. Food and Drug Administration (FDA) hasnt approved any medications for POTS treatment. But healthcare providers sometimes prescribe medications off-label to help certain POTS symptoms. […] These medications include: Fludrocortisone (increases salt retention and blood volume). Pyridostigmine (may reduce tachycardia). Midodrine (causes widespread vasoconstriction). Beta-blockers (may reduce upright tachycardia). […] Aside from exercise and dietary changes, other things you can do to manage POTS include frequently monitoring your pulse and blood pressure and getting quality sleep.

• #15 Dysautonomia International: Postural Orthostatic Tachycardia Syndrome

  http://www.dysautonomiainternational.org/page.php?ID=30

  Each patient is different, thus consulting with a physician who has experience in treating autonomic disorders is important. The most common treatments for POTS include increasing fluid intake to 2-3 liters per day; increasing salt consumption to 8,000 mg to 10,000 mg per day; wearing compression stockings; raising the head of the bed (to conserve blood volume); reclined exercises such as rowing, recumbent bicycling and swimming; a healthy diet; avoiding substances and situations that worsen orthostatic symptoms; and finally, the addition of medications meant to improve symptoms. Many different medications are used to treat POTS, such as Fludrocortisone, Beta Blockers, Midodrine, Clonidine, Pyridostigmine, Benzodiazepines, SSRIs, SNRIs, Erythropoietin and Octreotide. If an underlying cause of the POTS symptoms can be identified, treating the underlying cause is very important as well.

• #16 POTS: Diagnosing and treating this dizzying syndrome – Harvard Health

  https://www.health.harvard.edu/blog/pots-diagnosing-and-treating-this-dizzying-syndrome-202110062611

  Most of us don’t think twice about standing up. Yet for people affected by a disorder called postural orthostatic tachycardia syndrome (POTS), the simple act of standing can provoke lightheadedness and a racing heartbeat. This post discusses diagnosis, treatment, and living with POTS. […] While some people with POTS will require medications, most will improve with three behavioral changes alone: higher sodium (salt) intake, compression garments, and gradual exercise. […] One reason that people with POTS feel lightheaded upon standing is insufficient circulating blood volume. Drinking more fluids will help, but the key to keeping the fluids in circulation is sodium. […] Compression garments push blood into the deeper veins, preventing it from pooling in superficial veins of the lower legs. This is especially important during periods of standing, to help the body overcome the force of gravity.

• #17 Dysautonomia International: Postural Orthostatic Tachycardia Syndrome

  http://www.dysautonomiainternational.org/page.php?ID=30

  Each patient is different, thus consulting with a physician who has experience in treating autonomic disorders is important. The most common treatments for POTS include increasing fluid intake to 2-3 liters per day; increasing salt consumption to 8,000 mg to 10,000 mg per day; wearing compression stockings; raising the head of the bed (to conserve blood volume); reclined exercises such as rowing, recumbent bicycling and swimming; a healthy diet; avoiding substances and situations that worsen orthostatic symptoms; and finally, the addition of medications meant to improve symptoms. Many different medications are used to treat POTS, such as Fludrocortisone, Beta Blockers, Midodrine, Clonidine, Pyridostigmine, Benzodiazepines, SSRIs, SNRIs, Erythropoietin and Octreotide. If an underlying cause of the POTS symptoms can be identified, treating the underlying cause is very important as well.

• #18 Managing Symptoms of Postural Orthostatic Tachycardia Syndrome | Standing Up To POTS

  https://www.standinguptopots.org/livingwithpots/pots-tricks

  Unfortunately, there is not a one size fits all formula for managing the symptoms of postural orthostatic tachycardia syndrome (POTS). Just as each individual has a different combination of symptoms, each person has a unique response to treatment options. […] Some people respond very well to daily recumbent exercise, while for others dietary changes are more important. Talk with your doctor before making changes to your treatment regimen. […] Increase the salt intake. 6-10 grams of salt in pill form (SaltSticks, Thermotabs, other types) is often required in addition eating salty snacks and over-salting food. Salt helps POTS patients retain water in their blood vessels which elevates blood pressure to normal levels (or prevents it from falling when they stand). […] Individuals with POTS should be drinking approximately 2-3 LITERS of water, milk, or electrolyte drinks per day. When consuming high amounts of salt, you MUST have fluids to accompany them to prevent dehydration. Oral rehydration salts are the most effective way to ensure you’re getting a proper amount of sodium and water.

• #19 Postural Orthostatic Tachycardia Syndrome (PoTS Syndrome)

  https://patient.info/doctor/postural-tachycardia-syndrome-pots-pro

  Refer ideally to a physician with a special interest in PoTS syndrome. This will usually be a specialist cardiologist, a syncope clinic or an autonomic neurovascular clinic. […] Non-pharmacological management includes: Increase fluid intake (2-2.5 litres per day). Increase salt intake (3-5 g per day). (Not for the hyperadrenergic form.) Raise the head of bed. Exercises for the lower legs to improve muscle strength and pump action. Exercise programmes must be graduated. Compression stockings. Changing eating patterns – for example, eating smaller meals more frequently. Avoidance of alcohol and other trigger factors (such as heat or sitting still for long periods of time). Psychological support or cognitive behavioural therapy (CBT) may be required.

• #20 Managing Symptoms of Postural Orthostatic Tachycardia Syndrome | Standing Up To POTS

  https://www.standinguptopots.org/livingwithpots/pots-tricks

  We recommend using NormaLyte, a medical grade electrolyte oral rehydration salt, as it has been clinically proven to manage symptoms of POTS. […] Try abdominal compression, compression socks and/or gloves with 20-30 mm Hg of pressure. […] Tighten and relax leg muscles before standing. Pumping your ankles or tightening the muscles in your legs about 10 times before you stand can help to constrict your blood vessels and reduce symptoms when you stand. […] Exercise. As much as you may not feel like working out, research has shown that exercise can improve POTS symptoms better than beta blockers. Start slowly and add a minute or two every couple of days until you build up to 30 minutes of exercise five days a week. Recumbent exercise like swimming, rowing, or recumbent bikes are recommended as well as weight training and Pilates.

• #21 Postural Orthostatic Tachycardia Syndrome

  https://practicalneurology.com/articles/2020-mar-apr/postural-orthostatic-tachycardia-syndrome

  The current evidence for optimal management and treatment of POTS is extremely limited. Treatment options are symptom based, with no disease-modifying therapy available or even in development. Treatments can be divided into nonpharmacologic and pharmacologic strategies. The nonpharmacologic strategies target cardiovascular reconditioning and optimization and should be started and optimized before initiating pharmacologic treatments. Improvement in POTS symptoms can be expected with multimodal treatments. It is not well known, especially in pediatric and adolescent patients, how often the disorder may remit. In most series there is consistent improvement over time in the majority of patients. […] Increasing blood volume through increases in salt and fluid intake is the cornerstone of nonpharmacologic therapy. The optimal amount of fluid intake for individuals with POTS is unknown and very likely needs to be individualized for each person. In general, the recommendation is 1 to 3 L / day. Fluid alone, however, is likely insufficient to expand blood volume and needs to be paired with an increase in salt intake. Dietary salt intake is encouraged, but if insufficient, salt supplements can be considered. Salt tablets can cause gastrointestinal upset, so 0.5 to 1 g tablets of sodium are paired with meals, up to 3 times daily, to reduce intolerance. The maximum recommended amount of sodium is 10 g/day. Use of sports drinks containing electrolytes can help some individuals reach their sodium and fluid goals through the day.

• #22 POTS: Causes, Symptoms, Diagnosis & Treatment

  https://my.clevelandclinic.org/health/diseases/16560-postural-orthostatic-tachycardia-syndrome-pots

  Postural orthostatic tachycardia syndrome (POTS) is a condition that causes a number of symptoms when you transition from lying down to standing up, such as a fast heart rate, dizziness and fatigue. While theres no cure, several treatments and lifestyle changes can help manage the symptoms of POTS. […] Unfortunately, theres no cure for POTS. Instead, healthcare providers use several strategies to manage the symptoms of POTS. Treatment is highly individualized based on your symptoms and what works best for you. […] The main forms of treatment include: Exercise and physical activity. Diet and nutrition. […] Medical compression stockings can also help push blood up from your legs to reduce POTS symptoms. […] Exercise and physical activity are key to managing POTS. […] Studies show that reclined aerobic exercise, such as swimming, rowing and recumbent bicycling, has the best results. Strengthening your core and leg muscles is also helpful.

• #23 Natural Treatment for POTS – Institute for Natural Medicine

  https://naturemed.org/natural-treatment-for-pots/

  Exercise shows great promise for POTS relief, but with certain precautions. […] Research has demonstrated success for POTS patients who start with low-intensity exercise that doesnt involve standing up (such as rowing, swimming, or using a recumbent bike). […] Combining aerobic exercise (30 minutes, four days a week) and leg resistance training may also improve symptoms. […] It can take four to six weeks of regular exercise to see benefits. To help maintain the habit, try working out every other day for at least 30 minutes, and include aerobic exercise and resistance training (engaging the thigh muscles in particular). Ultimately, exercise is a treatment, not a cure. Without regular exercise, benefits quickly disappear. […] More salt and water increases blood volume, which can reduce a rapid heartbeat upon standing. Research recommends that people with POTS drink 2 to 3 liters of water daily and gradually work up to 8 to 10 daily grams of salt.

• #24 POTS: Causes, Symptoms, Diagnosis & Treatment

  https://my.clevelandclinic.org/health/diseases/16560-postural-orthostatic-tachycardia-syndrome-pots

  Postural orthostatic tachycardia syndrome (POTS) is a condition that causes a number of symptoms when you transition from lying down to standing up, such as a fast heart rate, dizziness and fatigue. While theres no cure, several treatments and lifestyle changes can help manage the symptoms of POTS. […] Unfortunately, theres no cure for POTS. Instead, healthcare providers use several strategies to manage the symptoms of POTS. Treatment is highly individualized based on your symptoms and what works best for you. […] The main forms of treatment include: Exercise and physical activity. Diet and nutrition. […] Medical compression stockings can also help push blood up from your legs to reduce POTS symptoms. […] Exercise and physical activity are key to managing POTS. […] Studies show that reclined aerobic exercise, such as swimming, rowing and recumbent bicycling, has the best results. Strengthening your core and leg muscles is also helpful.

• #25 Postural Tachycardia Syndrome (POTS) Diagnosis and Treatment: Basics and New Developments

  https://www.acc.org/Latest-in-Cardiology/Articles/2016/01/25/14/01/Postural-Tachycardia-Syndrome-POTS-Diagnosis-and-Treatment-Basics-and-New-Developments

  Exercise training is a reasonable first line therapy for many patients with POTS. […] Importantly, the Fu et al. exercise intervention reduced orthostatic tachycardia and improved quality of life, despite the relatively short duration. […] The initial pharmacological approach is to withdraw medications that might be predisposing to tachycardia (such as diuretics, vasodilators, and norepinephrine transporter blockers). […] The use of pharmacological agents should not be viewed as a replacement for an exercise program, but as an adjunct to an exercise program. […] Other medications used for POTS include midodrine, pyridostigmine and central sympatholytics. […] The focus of therapy should be an exercise reconditioning program, including both aerobic and resistance training, with an emphasis on non-upright exercises such as rowing machines, recumbent cycles and swimming. Pharmacological therapies targeting hypovolemia and the excess sympathetic nervous system activation may help relieve symptoms.

• #26 Natural Treatment for POTS – Institute for Natural Medicine

  https://naturemed.org/natural-treatment-for-pots/

  Exercise shows great promise for POTS relief, but with certain precautions. […] Research has demonstrated success for POTS patients who start with low-intensity exercise that doesnt involve standing up (such as rowing, swimming, or using a recumbent bike). […] Combining aerobic exercise (30 minutes, four days a week) and leg resistance training may also improve symptoms. […] It can take four to six weeks of regular exercise to see benefits. To help maintain the habit, try working out every other day for at least 30 minutes, and include aerobic exercise and resistance training (engaging the thigh muscles in particular). Ultimately, exercise is a treatment, not a cure. Without regular exercise, benefits quickly disappear. […] More salt and water increases blood volume, which can reduce a rapid heartbeat upon standing. Research recommends that people with POTS drink 2 to 3 liters of water daily and gradually work up to 8 to 10 daily grams of salt.

• #27 Postural Orthostatic Tachycardia Syndrome

  https://practicalneurology.com/articles/2020-mar-apr/postural-orthostatic-tachycardia-syndrome

  Exercise is necessary to improve cardiovascular endurance and reverse the deconditioning that is so often seen in POTS. People with POTS often report that overdoing it with exercise increases their symptoms. For that reason, a structured exercise program with gradually increasing intensity and duration of exercise is often prescribed. Exercise programs often begin with recumbent exercise to reduce orthostatic symptoms when upright. Targeted strength training in the lower body is thought to gradually improve venous return. Physical therapists and personal trainers can be allies in supervising exercise programs and helping individuals with POTS meet their exercise goals. […] Sleeping in a reverse Trendelenburg position has been recommended for people with POTS. The head of the bed should be elevated 4 to 6 inches higher than the foot of the bed. This is postulated to cause mild orthostatic stress, activating the renin-aldosterone system to increase total blood volume. Compression stockings are recommended as an additional measure to reduce venous pooling in the legs.

• #28 Natural Treatment for POTS – Institute for Natural Medicine

  https://naturemed.org/natural-treatment-for-pots/

  Exercise shows great promise for POTS relief, but with certain precautions. […] Research has demonstrated success for POTS patients who start with low-intensity exercise that doesnt involve standing up (such as rowing, swimming, or using a recumbent bike). […] Combining aerobic exercise (30 minutes, four days a week) and leg resistance training may also improve symptoms. […] It can take four to six weeks of regular exercise to see benefits. To help maintain the habit, try working out every other day for at least 30 minutes, and include aerobic exercise and resistance training (engaging the thigh muscles in particular). Ultimately, exercise is a treatment, not a cure. Without regular exercise, benefits quickly disappear. […] More salt and water increases blood volume, which can reduce a rapid heartbeat upon standing. Research recommends that people with POTS drink 2 to 3 liters of water daily and gradually work up to 8 to 10 daily grams of salt.

• #29 Managing Symptoms of Postural Orthostatic Tachycardia Syndrome | Standing Up To POTS

  https://www.standinguptopots.org/livingwithpots/pots-tricks

  We recommend using NormaLyte, a medical grade electrolyte oral rehydration salt, as it has been clinically proven to manage symptoms of POTS. […] Try abdominal compression, compression socks and/or gloves with 20-30 mm Hg of pressure. […] Tighten and relax leg muscles before standing. Pumping your ankles or tightening the muscles in your legs about 10 times before you stand can help to constrict your blood vessels and reduce symptoms when you stand. […] Exercise. As much as you may not feel like working out, research has shown that exercise can improve POTS symptoms better than beta blockers. Start slowly and add a minute or two every couple of days until you build up to 30 minutes of exercise five days a week. Recumbent exercise like swimming, rowing, or recumbent bikes are recommended as well as weight training and Pilates.

• #30 Natural Treatment for POTS – Institute for Natural Medicine

  https://naturemed.org/natural-treatment-for-pots/

  Exercise shows great promise for POTS relief, but with certain precautions. […] Research has demonstrated success for POTS patients who start with low-intensity exercise that doesnt involve standing up (such as rowing, swimming, or using a recumbent bike). […] Combining aerobic exercise (30 minutes, four days a week) and leg resistance training may also improve symptoms. […] It can take four to six weeks of regular exercise to see benefits. To help maintain the habit, try working out every other day for at least 30 minutes, and include aerobic exercise and resistance training (engaging the thigh muscles in particular). Ultimately, exercise is a treatment, not a cure. Without regular exercise, benefits quickly disappear. […] More salt and water increases blood volume, which can reduce a rapid heartbeat upon standing. Research recommends that people with POTS drink 2 to 3 liters of water daily and gradually work up to 8 to 10 daily grams of salt.

• #31 Get postural orthostatic tachycardia treatment | Cleveland Clinic

  https://my.clevelandclinic.org/services/pots-treatment

  Postural orthostatic tachycardia syndrome treatment involves therapies, education and self-care practices, like exercising. We tailor treatment recommendations to your needs. Recovery takes time. Its not uncommon for it to take six months to a year to feel better. Your treatment may include: […] Biofeedback, which uses painless sensors to measure your bodys autonomic response to treatment in real time. For example, easing muscle tension can lower your heart rate. […] Cardiac rehabilitation, which is a medically supervised exercise program that provides a safe environment for learning to exercise. […] Medications, which may control your heart rate, improve blood flow or raise blood pressure. You may also need headache medicine if your POTS symptoms include migraines. […] Talk therapy, which involves meeting with our health psychologist. These conversations help you cope with the challenges of living with POTS.

• #32 POTS: Diagnosing and treating this dizzying syndrome – Harvard Health

  https://www.health.harvard.edu/blog/pots-diagnosing-and-treating-this-dizzying-syndrome-202110062611

  Most of us don’t think twice about standing up. Yet for people affected by a disorder called postural orthostatic tachycardia syndrome (POTS), the simple act of standing can provoke lightheadedness and a racing heartbeat. This post discusses diagnosis, treatment, and living with POTS. […] While some people with POTS will require medications, most will improve with three behavioral changes alone: higher sodium (salt) intake, compression garments, and gradual exercise. […] One reason that people with POTS feel lightheaded upon standing is insufficient circulating blood volume. Drinking more fluids will help, but the key to keeping the fluids in circulation is sodium. […] Compression garments push blood into the deeper veins, preventing it from pooling in superficial veins of the lower legs. This is especially important during periods of standing, to help the body overcome the force of gravity.

• #33 Postural Tachycardia Syndrome (POTS) Diagnosis and Treatment: Basics and New Developments

  https://www.acc.org/Latest-in-Cardiology/Articles/2016/01/25/14/01/Postural-Tachycardia-Syndrome-POTS-Diagnosis-and-Treatment-Basics-and-New-Developments

  POTS is defined as the presence of chronic symptoms of orthostatic intolerance (6 months) accompanied by an increased heart rate (HR) 30 bpm within 10 minutes of assuming an upright posture and in the absence of orthostatic hypotension (blood pressure [BP] fall 20/10 mmHg). […] Treatment efforts should begin by correcting reversible causes and optimizing chronic disease management. Patient education is important. If there has been a bout of prolonged bed rest, symptoms should gradually improve as patients recondition themselves to upright posture. POTS patients should avoid aggravating factors such as dehydration, and extreme heat. In an effort to optimize hydration, we patients are asked to consume 8-10 cups of water daily and to increase their sodium intake to up to 8-10 g/day. This should ideally be accomplished by dietary modification. We recommend panty-hose (waist high) style compression stockings with 30-40 mmHg of counter-pressure to minimize peripheral venous pooling and to enhance venous return. Elevating the head of the bed up on blocks 4-6 inches may also be helpful to facilitate expansion of the plasma volume.

• #34 POTS: Diagnosing and treating this dizzying syndrome – Harvard Health

  https://www.health.harvard.edu/blog/pots-diagnosing-and-treating-this-dizzying-syndrome-202110062611

  Most of us don’t think twice about standing up. Yet for people affected by a disorder called postural orthostatic tachycardia syndrome (POTS), the simple act of standing can provoke lightheadedness and a racing heartbeat. This post discusses diagnosis, treatment, and living with POTS. […] While some people with POTS will require medications, most will improve with three behavioral changes alone: higher sodium (salt) intake, compression garments, and gradual exercise. […] One reason that people with POTS feel lightheaded upon standing is insufficient circulating blood volume. Drinking more fluids will help, but the key to keeping the fluids in circulation is sodium. […] Compression garments push blood into the deeper veins, preventing it from pooling in superficial veins of the lower legs. This is especially important during periods of standing, to help the body overcome the force of gravity.

• #35 Postural Orthostatic Tachycardia Syndrome (POTS) – Child Neurology Foundation

  https://www.childneurologyfoundation.org/disorder/postural-orthostatic-tachycardia-syndrome-pots/

  Postural Orthostatic Tachycardia Syndrome (POTS) Home / Postural Orthostatic Tachycardia Syndrome (POTS) Return to Disorder Directory […] Initial and first-line treatments of POTS include: […] Increasing hydration. Most adults and adolescents should drink about 64 ounces (2 liters) of fluid a day. Some people with POTS need up to 100 ounces (3 liters) of fluid a day. […] Extra salt intake. Salt helps hold fluid in the blood stream, increasing blood volume. Extra salt intake can be helpful in POTS. Consuming 3 to 10 grams of salt per day may be appropriate. […] Exercise. Exercise is very important for managing POTS symptoms and decreasing them over time. […] Additional treatments include: […] Diet. Many people with POTS feel better if they eat small meals throughout the day. […] Compression clothing. Compression stockings, compression tights, and abdominal binders may help increase blood pressure when standing.

• #36 POTS: Diagnosing and treating this dizzying syndrome – Harvard Health

  https://www.health.harvard.edu/blog/pots-diagnosing-and-treating-this-dizzying-syndrome-202110062611

  Most of us don’t think twice about standing up. Yet for people affected by a disorder called postural orthostatic tachycardia syndrome (POTS), the simple act of standing can provoke lightheadedness and a racing heartbeat. This post discusses diagnosis, treatment, and living with POTS. […] While some people with POTS will require medications, most will improve with three behavioral changes alone: higher sodium (salt) intake, compression garments, and gradual exercise. […] One reason that people with POTS feel lightheaded upon standing is insufficient circulating blood volume. Drinking more fluids will help, but the key to keeping the fluids in circulation is sodium. […] Compression garments push blood into the deeper veins, preventing it from pooling in superficial veins of the lower legs. This is especially important during periods of standing, to help the body overcome the force of gravity.

• #37 POTS: Causes, Symptoms, Diagnosis & Treatment

  https://my.clevelandclinic.org/health/diseases/16560-postural-orthostatic-tachycardia-syndrome-pots

  Managing diet and nutrition is another important aspect of managing POTS symptoms. […] If you have the hypovolemic (low blood volume) form of POTS, your healthcare provider will likely recommend increasing both your fluid and salt intake to increase blood volume. […] The U.S. Food and Drug Administration (FDA) hasnt approved any medications for POTS treatment. But healthcare providers sometimes prescribe medications off-label to help certain POTS symptoms. […] These medications include: Fludrocortisone (increases salt retention and blood volume). Pyridostigmine (may reduce tachycardia). Midodrine (causes widespread vasoconstriction). Beta-blockers (may reduce upright tachycardia). […] Aside from exercise and dietary changes, other things you can do to manage POTS include frequently monitoring your pulse and blood pressure and getting quality sleep.

• #38 POTS: Diagnosing and treating this dizzying syndrome – Harvard Health

  https://www.health.harvard.edu/blog/pots-diagnosing-and-treating-this-dizzying-syndrome-202110062611

  A cornerstone of POTS treatment is a slow, consistent, gradual return to exercise. […] Yes. Along with salt, compression, and exercise, I recommended that David try placing a small board under his mattress that raises the head of his bed by a few inches, using a symptom-tracking smartphone app to help identify triggers for POTS symptoms, avoiding identified triggers, such as skipping meals; insufficient sleep; alcoholic beverages; hot baths and saunas; and high-carbohydrate meals. […] Some people find that behavioral changes must be combined with medicines to properly treat their symptoms. Currently, no medications have been approved by the FDA to treat POTS. However, several medicines can be prescribed off-label when needed. Your doctor might suggest one or more of these: fludrocortisone (helps the kidneys retain sodium), midodrine (causes the blood vessels to tighten), beta blockers (slow down the heart rate), pyridostigmine (enhances neurotransmitter activity). […] By consistently paying attention to sodium and fluid intake, compression, and exercise, as well as the behavioral changes and medicines discussed above, many people who have POTS can successfully attend school and hold down jobs. However, symptoms may flare without warning.

• #39 Teens and POTS (Postural Orthostatic Tachycardia Syndrome) – The Dysautonomia Project

  https://thedysautonomiaproject.org/teens-and-pots-postural-orthostatic-tachycardia-syndrome/

  Non-Pharmacological Strategies: Increasing water intake to keep your blood volume up (2-3 liters fluid daily is recommended). […] Adding sodium (salt) to your daily intake. Salt helps to retain fluid volume in your (5-9 grams of salt daily is recommended). […] Movement and/or exercise daily is recommended. Some patients may benefit from physical therapy, aquatic therapy, cardiac rehab. […] Diet changes: Eat smaller, more frequent meals to aid in digestion. Large meals worsen dizziness because they shunt up to five times more blood into the abdominal area. This causes a drop in blood pressure also known as postprandial hypotension). Some patients find it helpful to incorporate salty snacks. […] Wearing compression garments to avoid excessive pooling of blood in the legs and abdominal area.

• #40 Postural tachycardia syndrome (PoTS)

  https://www.nhs.uk/conditions/postural-tachycardia-syndrome/

  There’s currently no cure, but it can be managed with changes to your lifestyle, or sometimes treatment with medicines. […] A GP or specialist may suggest lifestyle changes first, such as drinking more fluids, eating small meals low in refined carbohydrates, and wearing compression clothing. […] You may be prescribed medicines to help control your symptoms, such as steroids, medicines used to treat heart conditions and manage your blood pressure, and selective serotonin reuptake inhibitors (SSRIs). […] You may also need to try several different medicines or combinations of medicines.

• #41 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment in Delhi, India

  https://www.maxhealthcare.in/our-specialities/cardiology/conditions-treatments/postural-orthostatic-tachycardia-syndrome

  Yoga: Start doing yoga and meditation on a regular basis. […] Diet control: Managing diet and nutrition also controls the symptoms of POTS. It is advised to increase salt and fluid intake in the diet to improve blood volume. General guidelines for dietary changes include: […] Consume 2 to 2.5 litres per day of fluids. […] Taking small and intermittent meals instead of a few large meals with longer breaks in between. […] Consumption of a high-fibre diet and carbohydrates helps in the reduction of blood glucose levels and reduces the symptoms of POTS. […] Include things like broth, pickles, olives, sardines, anchovies and nuts in the diet. […] Medications

• #42 Postural Orthostatic Tachycardia Syndrome Symptoms & Treatment

  https://drbrighten.com/postural-orthostatic-tachycardia-syndrome/

  Postural Orthostatic Tachycardia Syndrome (POTS) Treatment […] Treatment for POTS often involves lifestyle changes, supportive therapies, and sometimes medications. Here’s more about these approaches: […] Hydration and electrolytes: Drinking plenty of fluids (such as 64-80 ounces or about 2-2.5 liters a day) and LMNT (like sodium) helps your body maintain adequate blood volume. […] Avoiding caffeine and alcohol: Limiting alcohol and stimulants like coffee can help manage symptoms since these can interfere with fluid balance and also tend to worsen feelings of dizziness, jitters, and instability. […] Compression garments: Wearing compression socks or abdominal binders can help support circulation and reduce blood pooling in the legs. […] Slow posture changes: Avoid jumping out of bed or standing up too quickly to prevent sudden heart rate spikes.

• #43 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment in Delhi, India

  https://www.maxhealthcare.in/our-specialities/cardiology/conditions-treatments/postural-orthostatic-tachycardia-syndrome

  Yoga: Start doing yoga and meditation on a regular basis. […] Diet control: Managing diet and nutrition also controls the symptoms of POTS. It is advised to increase salt and fluid intake in the diet to improve blood volume. General guidelines for dietary changes include: […] Consume 2 to 2.5 litres per day of fluids. […] Taking small and intermittent meals instead of a few large meals with longer breaks in between. […] Consumption of a high-fibre diet and carbohydrates helps in the reduction of blood glucose levels and reduces the symptoms of POTS. […] Include things like broth, pickles, olives, sardines, anchovies and nuts in the diet. […] Medications

• #44 POTS-associated Conditions and Management Strategies | USC Journal

  https://www.uscjournal.com/articles/narrative-review-postural-orthostatic-tachycardia-syndrome-associated-conditions-and?language_content_entity=en

  Compression stockings are useful for decreasing lower extremity blood pooling and increasing venous return, although the stockings should reach at least the thigh for maximum benefit. […] Dietary changes can significantly improve the quality of life of POTS patients. […] Pharmacologic Therapies […] Currently, there are no Food and Drug Administration (FDA)-approved treatments for POTS, and pharmacologic agents used in POTS patients are considered off-label. […] Medications That Target Vascular Tone […] Midodrine, an α1-adrenergic agonist, is an effective treatment for POTS secondary to abnormal vascular tone by increasing vasoconstriction and, consequently, improving venous return to the heart. […] Medications That Target Rapid Heart Rate […] β-blockers are frequently used for tachycardia in POTS patients.

• #45 Postural Tachycardia Syndrome (POTS) Diagnosis and Treatment: Basics and New Developments

  https://www.acc.org/Latest-in-Cardiology/Articles/2016/01/25/14/01/Postural-Tachycardia-Syndrome-POTS-Diagnosis-and-Treatment-Basics-and-New-Developments

  POTS is defined as the presence of chronic symptoms of orthostatic intolerance (6 months) accompanied by an increased heart rate (HR) 30 bpm within 10 minutes of assuming an upright posture and in the absence of orthostatic hypotension (blood pressure [BP] fall 20/10 mmHg). […] Treatment efforts should begin by correcting reversible causes and optimizing chronic disease management. Patient education is important. If there has been a bout of prolonged bed rest, symptoms should gradually improve as patients recondition themselves to upright posture. POTS patients should avoid aggravating factors such as dehydration, and extreme heat. In an effort to optimize hydration, we patients are asked to consume 8-10 cups of water daily and to increase their sodium intake to up to 8-10 g/day. This should ideally be accomplished by dietary modification. We recommend panty-hose (waist high) style compression stockings with 30-40 mmHg of counter-pressure to minimize peripheral venous pooling and to enhance venous return. Elevating the head of the bed up on blocks 4-6 inches may also be helpful to facilitate expansion of the plasma volume.

• #46 Postural Orthostatic Tachycardia Syndrome

  https://practicalneurology.com/articles/2020-mar-apr/postural-orthostatic-tachycardia-syndrome

  Exercise is necessary to improve cardiovascular endurance and reverse the deconditioning that is so often seen in POTS. People with POTS often report that overdoing it with exercise increases their symptoms. For that reason, a structured exercise program with gradually increasing intensity and duration of exercise is often prescribed. Exercise programs often begin with recumbent exercise to reduce orthostatic symptoms when upright. Targeted strength training in the lower body is thought to gradually improve venous return. Physical therapists and personal trainers can be allies in supervising exercise programs and helping individuals with POTS meet their exercise goals. […] Sleeping in a reverse Trendelenburg position has been recommended for people with POTS. The head of the bed should be elevated 4 to 6 inches higher than the foot of the bed. This is postulated to cause mild orthostatic stress, activating the renin-aldosterone system to increase total blood volume. Compression stockings are recommended as an additional measure to reduce venous pooling in the legs.

• #47 Postural orthostatic tachycardia syndrome (POTS) | Healthify

  https://healthify.nz/health-a-z/p/postural-orthostatic-tachycardia-syndrome-pots/

  The self-care measures described below can sometimes help to reduce the symptoms of POTS. If these do not work, you may need to take medicine. The important thing is to understand the issue and not panic. […] There are 3 main approaches to treating POTS: treating an episode, taking preventative steps to reduce your symptoms and taking medication. […] If you suddenly feel faint or dizzy, try to counter the fall in blood flow by: lying down and, if you can, raising your legs; crossing your legs in front of each other while standing; rocking up and down on your toes; clenching your buttocks and tummy muscles; clenching your fists if you cant lie down. […] You may be able to reduce your symptoms in the long term if you: drink plenty of fluids until your pee is pale yellow; keep active, but pace yourself and choose your exercise carefully swimming, rowing, lower limb resistance training, walking, jogging and Pilates can help you keep fit and build muscle (strong calf muscles should help pump blood back to your heart); raise the head end of your bed, so you’re not sleeping fully flat; try wearing support tights or other forms of compression clothing, to improve blood flow in your legs; avoid long periods of standing, particularly in the heat; avoid long, hot showers; cross your legs and draw up your knees if sitting for long periods of time; get up slowly after lying down and sit for a while before standing; avoid drinking lots of caffeine or alcohol; add more salt to your diet through the day (provided you dont have high blood pressure or kidney or heart disease); use electrolyte drinks in hot weather or before sport, when you may sweat a lot.

• #48 Postural Orthostatic Tachycardia Syndrome – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK541074/

  Other conservative non-pharmacologic interventions include physical counter maneuvers (muscle contraction, leg crossing, forward bending), compression garments, increased fluid (2-3 liters) and salt (slowly up to 10 grams) intake, and avoidance of symptom exacerbation (caffeine, alcohol, prolonged heat exposure). […] Pharmacologic therapies (class IIb) are not considered first-line treatment for POTS and enter the clinical picture in severe or refractory cases with the goal of stabilization for continued physical reconditioning. […] The following medications are used off-label. […] Fludrocortisone, a synthetic mineralocorticoid aldosterone analog, increases salt retention and plasma volume. […] The alpha-1-adrenergic agonist midodrine causes systemic vasoconstriction leading to an increase in venous return that may be effective in hypotensive phenotypes.

• #49 POTS: Diagnosing and treating this dizzying syndrome – Harvard Health

  https://www.health.harvard.edu/blog/pots-diagnosing-and-treating-this-dizzying-syndrome-202110062611

  A cornerstone of POTS treatment is a slow, consistent, gradual return to exercise. […] Yes. Along with salt, compression, and exercise, I recommended that David try placing a small board under his mattress that raises the head of his bed by a few inches, using a symptom-tracking smartphone app to help identify triggers for POTS symptoms, avoiding identified triggers, such as skipping meals; insufficient sleep; alcoholic beverages; hot baths and saunas; and high-carbohydrate meals. […] Some people find that behavioral changes must be combined with medicines to properly treat their symptoms. Currently, no medications have been approved by the FDA to treat POTS. However, several medicines can be prescribed off-label when needed. Your doctor might suggest one or more of these: fludrocortisone (helps the kidneys retain sodium), midodrine (causes the blood vessels to tighten), beta blockers (slow down the heart rate), pyridostigmine (enhances neurotransmitter activity). […] By consistently paying attention to sodium and fluid intake, compression, and exercise, as well as the behavioral changes and medicines discussed above, many people who have POTS can successfully attend school and hold down jobs. However, symptoms may flare without warning.

• #50

  https://www.healthychildren.org/English/health-issues/conditions/heart/Pages/Postural-Orthostatic-Tachycardia-Syndrome-POTS.aspx

  There is no perfect treatment for POTS. Treatment is individualized to each child’s specific symptoms, and recommendations may include: […] Increasing water intake to at least 60-80 ounces per day (depending upon the child’s size) and an increase in the amount of salt in the diet. Together, these help to retain fluid and fill up the overly relaxed blood vessels. […] Getting lots of sleep- up to 10 hours a night. […] Sleeping with the head of the bed mildly raised. Over time, this decreases morning symptoms of dizziness as the nervous system is retrained. […] Exercising. Gentle workouts at first and gradually increasing to moderate exercise daily. To start, exercises need to be those where the child is not upright, like swimming, recumbent biking, or rowing. Improving leg and core strength improves blood return from the legs. Exercise also improves fitness and energy, and helps to retrain the nervous system over time.

• #51 POTS: Diagnosing and treating this dizzying syndrome – Harvard Health

  https://www.health.harvard.edu/blog/pots-diagnosing-and-treating-this-dizzying-syndrome-202110062611

  A cornerstone of POTS treatment is a slow, consistent, gradual return to exercise. […] Yes. Along with salt, compression, and exercise, I recommended that David try placing a small board under his mattress that raises the head of his bed by a few inches, using a symptom-tracking smartphone app to help identify triggers for POTS symptoms, avoiding identified triggers, such as skipping meals; insufficient sleep; alcoholic beverages; hot baths and saunas; and high-carbohydrate meals. […] Some people find that behavioral changes must be combined with medicines to properly treat their symptoms. Currently, no medications have been approved by the FDA to treat POTS. However, several medicines can be prescribed off-label when needed. Your doctor might suggest one or more of these: fludrocortisone (helps the kidneys retain sodium), midodrine (causes the blood vessels to tighten), beta blockers (slow down the heart rate), pyridostigmine (enhances neurotransmitter activity). […] By consistently paying attention to sodium and fluid intake, compression, and exercise, as well as the behavioral changes and medicines discussed above, many people who have POTS can successfully attend school and hold down jobs. However, symptoms may flare without warning.

• #52 Postural tachycardia syndrome (PoTS)

  https://www.nhs.uk/conditions/postural-tachycardia-syndrome/

  There’s currently no cure, but it can be managed with changes to your lifestyle, or sometimes treatment with medicines. […] A GP or specialist may suggest lifestyle changes first, such as drinking more fluids, eating small meals low in refined carbohydrates, and wearing compression clothing. […] You may be prescribed medicines to help control your symptoms, such as steroids, medicines used to treat heart conditions and manage your blood pressure, and selective serotonin reuptake inhibitors (SSRIs). […] You may also need to try several different medicines or combinations of medicines.

• #53 POTS-associated Conditions and Management Strategies | USC Journal

  https://www.uscjournal.com/articles/narrative-review-postural-orthostatic-tachycardia-syndrome-associated-conditions-and?language_content_entity=en

  Ivabradine, a drug approved by the FDA for symptomatic heart failure with reduced ejection fraction, is being increasingly used in POTS patients due to its cardiac selectivity. […] Pyridostigmine acts to inhibit acetylcholinesterase, increasing the availability of acetylcholine at ganglionic nicotinic receptors and postganglionic muscarinic receptors. […] Medications That Target Hypovolemia […] In addition to salt supplementation, fludrocortisone, a glucocorticoid that acts similarly to aldosterone, has shown efficacy in improving POTS symptoms. […] Therapies directed towards mast cell activation may also provide benefit in patients with POTS, particularly those with suspected coexisting MCAS. […] For patients with autoimmune-associated POTS, particularly those diagnosed with SFN, IVIG and plasmapheresis have demonstrated improvement in symptoms.

• #54 Postural orthostatic tachycardia syndrome – Wikipedia

  https://en.wikipedia.org/wiki/Postural_orthostatic_tachycardia_syndrome

  Fludrocortisone, a mineralocorticoid, may be used to enhance sodium retention and blood volume, which may be beneficial not only by augmenting sympathetically mediated vasoconstriction, but also because a large subset of POTS patients appear to have low absolute blood volume. […] While people with POTS typically have normal or even elevated arterial blood pressure, the neuropathic form of POTS is presumed to constitute a selective sympathetic venous denervation. In these patients the selective 1-adrenergic receptor agonist midodrine may increase venous return, enhance stroke volume, and improve symptoms. […] Sinus node blocker ivabradine can successfully restrain heart rate in POTS without affecting blood pressure, demonstrated in approximately 60% of people with POTS treated in an open-label trial of ivabradine experienced symptom improvement.

• #55 Medications for POTS | Standing Up To POTS

  https://www.standinguptopots.org/resources/medicine

  Generally recommended for those with hyperadrenergic POTS and hypertensive tendency on standing (Fedorowski 2018). […] Particularly helpful in patients with suspected autonomic neuropathy, gastrointestinal dysfunction and non-specific muscle weakness (Fedorowski 2018). […] Recommended for the hypovolemic subtype of POTS and those with low blood pressure. […] Effective in hypovolemic subtype of POTS and low blood pressure phenotype with pronounced orthostatic intolerance (Fedorowski 2018). […] This medication is a synthetic version of antidiuretic hormone, and helps the body retain water which can increase blood pressure. […] In acute decompensated POTS, IV fluids can alleviate short-term symptoms (Fedorowski 2018). […] These are the same medications that can be used for individuals who have Attention Deficit Disorder. For POTS, they are used for those experiencing significant fatigue and brain fog.

• #56 Postural Orthostatic Tachycardia Syndrome (POTS): Evaluation and Management | British Journal of Medical Practitioners

  https://www.bjmp.org/content/postural-orthostatic-tachycardia-syndrome-pots-evaluation-and-management

  The goal of pharmacotherapy in the treatment of POTS is to ameliorate the symptoms of POTS and thus maintain the functional capacity. Currently no drug is US FDA approved for the treatment of POTS. All pharmacology is inherently off-label. […] Majority of the evidence for the use of different pharmacological agents in the management of POTS is based on some small randomised, observational and retrospective single center studies. In clinical practice most patients are treated with a single agent and second medication from different class with a different mechanism of action is added in case of treatment failure. Resistant cases are often treated with polypharmacy. […] Fludrocortisone, a potent mineralocorticoid resulting in sodium retention, augmented fluid volume, and sensitized peripheral alpha adrenergic receptors. The effects are more pronounced in the younger population. Starting dose is 0.1-0.2 mg daily with a maximum dose of 0.4 mg. Common side effects include electrolyte imbalance and hypertension. In a study of 11 female POTS patients, fludricortisone alone or in combination with bisoprolol was associated with improvement in symptoms. Midodrine is an alpha-1 adrenoreceptor agonist and causes both arterial and venous vasoconstriction. It is commonly used as add on therapy and with starting dose at 5 mg orally three times a day. In our clinical experience we advise patients to take their first dose of midodrine 15 minutes prior to getting out of bed. An additional 5mg dose can be used for breakthrough symptoms. Midodrine is usually well tolerated with the most common complaints being nausea, goose bumps, and scalp pruritus.

• #57 Postural Orthostatic Tachycardia Syndrome (POTS): Evaluation and Management | British Journal of Medical Practitioners

  https://www.bjmp.org/content/postural-orthostatic-tachycardia-syndrome-pots-evaluation-and-management

  The goal of pharmacotherapy in the treatment of POTS is to ameliorate the symptoms of POTS and thus maintain the functional capacity. Currently no drug is US FDA approved for the treatment of POTS. All pharmacology is inherently off-label. […] Majority of the evidence for the use of different pharmacological agents in the management of POTS is based on some small randomised, observational and retrospective single center studies. In clinical practice most patients are treated with a single agent and second medication from different class with a different mechanism of action is added in case of treatment failure. Resistant cases are often treated with polypharmacy. […] Fludrocortisone, a potent mineralocorticoid resulting in sodium retention, augmented fluid volume, and sensitized peripheral alpha adrenergic receptors. The effects are more pronounced in the younger population. Starting dose is 0.1-0.2 mg daily with a maximum dose of 0.4 mg. Common side effects include electrolyte imbalance and hypertension. In a study of 11 female POTS patients, fludricortisone alone or in combination with bisoprolol was associated with improvement in symptoms. Midodrine is an alpha-1 adrenoreceptor agonist and causes both arterial and venous vasoconstriction. It is commonly used as add on therapy and with starting dose at 5 mg orally three times a day. In our clinical experience we advise patients to take their first dose of midodrine 15 minutes prior to getting out of bed. An additional 5mg dose can be used for breakthrough symptoms. Midodrine is usually well tolerated with the most common complaints being nausea, goose bumps, and scalp pruritus.

• #58 Medication Overview | PoTS UK

  https://www.potsuk.org/managingpots/medication-2/

  SNRIs may worsen tachycardia in patients with PoTS. […] Fludrocortisione is a mineralocorticoid, licensed for use in orthostatic hypotension, the action of which is to retain salt and water. […] Desmopressin is a hormone that reduces urine production, promotes fluid retention and therefore decreases heart rate, improving symptoms of PoTS. […] Clonidine or Methyldopa may be used in Hyperadrenergic PoTS. […] Modafinil is a stimulant normally used in some sleep disorders, and may improve alertness and decrease mental clouding in those with PoTS.

• #59 Postural Orthostatic Tachycardia Syndrome

  https://practicalneurology.com/articles/2020-mar-apr/postural-orthostatic-tachycardia-syndrome

  Pharmacologic treatments can be added to address POTS symptoms when nonpharmacologic treatments are insufficient. Medication can be used to expand blood volume, reduce heart rate, induce peripheral vasoconstriction, and for sympatholysis. Medications can also be used to target the comorbidities of POTS; these are symptom driven. […] Fludrocortisone is a mineralocorticoid that increases blood volume through activation of the renin-aldosterone system. Doses up to 0.2 mg/day do not suppress the hypothalamic-pituitary axis and are well tolerated. Desmopressin (DDAVP) is an antidiuretic hormone that promotes free water retention. Electrolyte levels should be monitored with chronic use to avoid hyponatremia, which can occur with high-volume free-water intake. Midodrine is a potent vasoconstrictor that has several actions, including increasing blood pressure, venous return, cardiac preload, and stroke volume. Midodrine should be taken only when awake, however, because it can cause supine hypertension. Beta blockers, most commonly metoprolol in children and adolescents, are used to decrease heart rate and can be of great benefit for those with symptomatic palpitations. However, metoprolol can cause exercise intolerance and hypotension.

• #60 Postural Orthostatic Tachycardia Syndrome

  https://practicalneurology.com/articles/2020-mar-apr/postural-orthostatic-tachycardia-syndrome

  Pharmacologic treatments can be added to address POTS symptoms when nonpharmacologic treatments are insufficient. Medication can be used to expand blood volume, reduce heart rate, induce peripheral vasoconstriction, and for sympatholysis. Medications can also be used to target the comorbidities of POTS; these are symptom driven. […] Fludrocortisone is a mineralocorticoid that increases blood volume through activation of the renin-aldosterone system. Doses up to 0.2 mg/day do not suppress the hypothalamic-pituitary axis and are well tolerated. Desmopressin (DDAVP) is an antidiuretic hormone that promotes free water retention. Electrolyte levels should be monitored with chronic use to avoid hyponatremia, which can occur with high-volume free-water intake. Midodrine is a potent vasoconstrictor that has several actions, including increasing blood pressure, venous return, cardiac preload, and stroke volume. Midodrine should be taken only when awake, however, because it can cause supine hypertension. Beta blockers, most commonly metoprolol in children and adolescents, are used to decrease heart rate and can be of great benefit for those with symptomatic palpitations. However, metoprolol can cause exercise intolerance and hypotension.

• #61 Medications for POTS | Standing Up To POTS

  https://www.standinguptopots.org/resources/medicine

  Generally recommended for those with hyperadrenergic POTS and hypertensive tendency on standing (Fedorowski 2018). […] Particularly helpful in patients with suspected autonomic neuropathy, gastrointestinal dysfunction and non-specific muscle weakness (Fedorowski 2018). […] Recommended for the hypovolemic subtype of POTS and those with low blood pressure. […] Effective in hypovolemic subtype of POTS and low blood pressure phenotype with pronounced orthostatic intolerance (Fedorowski 2018). […] This medication is a synthetic version of antidiuretic hormone, and helps the body retain water which can increase blood pressure. […] In acute decompensated POTS, IV fluids can alleviate short-term symptoms (Fedorowski 2018). […] These are the same medications that can be used for individuals who have Attention Deficit Disorder. For POTS, they are used for those experiencing significant fatigue and brain fog.

• #62 POTS-associated Conditions and Management Strategies | USC Journal

  https://www.uscjournal.com/articles/narrative-review-postural-orthostatic-tachycardia-syndrome-associated-conditions-and?language_content_entity=en

  Compression stockings are useful for decreasing lower extremity blood pooling and increasing venous return, although the stockings should reach at least the thigh for maximum benefit. […] Dietary changes can significantly improve the quality of life of POTS patients. […] Pharmacologic Therapies […] Currently, there are no Food and Drug Administration (FDA)-approved treatments for POTS, and pharmacologic agents used in POTS patients are considered off-label. […] Medications That Target Vascular Tone […] Midodrine, an α1-adrenergic agonist, is an effective treatment for POTS secondary to abnormal vascular tone by increasing vasoconstriction and, consequently, improving venous return to the heart. […] Medications That Target Rapid Heart Rate […] β-blockers are frequently used for tachycardia in POTS patients.

• #63 Postural Orthostatic Tachycardia Syndrome (POTS): Evaluation and Management | British Journal of Medical Practitioners

  https://www.bjmp.org/content/postural-orthostatic-tachycardia-syndrome-pots-evaluation-and-management

  The goal of pharmacotherapy in the treatment of POTS is to ameliorate the symptoms of POTS and thus maintain the functional capacity. Currently no drug is US FDA approved for the treatment of POTS. All pharmacology is inherently off-label. […] Majority of the evidence for the use of different pharmacological agents in the management of POTS is based on some small randomised, observational and retrospective single center studies. In clinical practice most patients are treated with a single agent and second medication from different class with a different mechanism of action is added in case of treatment failure. Resistant cases are often treated with polypharmacy. […] Fludrocortisone, a potent mineralocorticoid resulting in sodium retention, augmented fluid volume, and sensitized peripheral alpha adrenergic receptors. The effects are more pronounced in the younger population. Starting dose is 0.1-0.2 mg daily with a maximum dose of 0.4 mg. Common side effects include electrolyte imbalance and hypertension. In a study of 11 female POTS patients, fludricortisone alone or in combination with bisoprolol was associated with improvement in symptoms. Midodrine is an alpha-1 adrenoreceptor agonist and causes both arterial and venous vasoconstriction. It is commonly used as add on therapy and with starting dose at 5 mg orally three times a day. In our clinical experience we advise patients to take their first dose of midodrine 15 minutes prior to getting out of bed. An additional 5mg dose can be used for breakthrough symptoms. Midodrine is usually well tolerated with the most common complaints being nausea, goose bumps, and scalp pruritus.

• #64 Postural Orthostatic Tachycardia Syndrome (POTS): Evaluation and Management | British Journal of Medical Practitioners

  https://www.bjmp.org/content/postural-orthostatic-tachycardia-syndrome-pots-evaluation-and-management

  The goal of pharmacotherapy in the treatment of POTS is to ameliorate the symptoms of POTS and thus maintain the functional capacity. Currently no drug is US FDA approved for the treatment of POTS. All pharmacology is inherently off-label. […] Majority of the evidence for the use of different pharmacological agents in the management of POTS is based on some small randomised, observational and retrospective single center studies. In clinical practice most patients are treated with a single agent and second medication from different class with a different mechanism of action is added in case of treatment failure. Resistant cases are often treated with polypharmacy. […] Fludrocortisone, a potent mineralocorticoid resulting in sodium retention, augmented fluid volume, and sensitized peripheral alpha adrenergic receptors. The effects are more pronounced in the younger population. Starting dose is 0.1-0.2 mg daily with a maximum dose of 0.4 mg. Common side effects include electrolyte imbalance and hypertension. In a study of 11 female POTS patients, fludricortisone alone or in combination with bisoprolol was associated with improvement in symptoms. Midodrine is an alpha-1 adrenoreceptor agonist and causes both arterial and venous vasoconstriction. It is commonly used as add on therapy and with starting dose at 5 mg orally three times a day. In our clinical experience we advise patients to take their first dose of midodrine 15 minutes prior to getting out of bed. An additional 5mg dose can be used for breakthrough symptoms. Midodrine is usually well tolerated with the most common complaints being nausea, goose bumps, and scalp pruritus.

• #65 Medications for POTS | Standing Up To POTS

  https://www.standinguptopots.org/resources/medicine

  Generally recommended for those with hyperadrenergic POTS and hypertensive tendency on standing (Fedorowski 2018). […] Particularly helpful in patients with suspected autonomic neuropathy, gastrointestinal dysfunction and non-specific muscle weakness (Fedorowski 2018). […] Recommended for the hypovolemic subtype of POTS and those with low blood pressure. […] Effective in hypovolemic subtype of POTS and low blood pressure phenotype with pronounced orthostatic intolerance (Fedorowski 2018). […] This medication is a synthetic version of antidiuretic hormone, and helps the body retain water which can increase blood pressure. […] In acute decompensated POTS, IV fluids can alleviate short-term symptoms (Fedorowski 2018). […] These are the same medications that can be used for individuals who have Attention Deficit Disorder. For POTS, they are used for those experiencing significant fatigue and brain fog.

• #66 Postural Orthostatic Tachycardia Syndrome

  https://practicalneurology.com/articles/2020-mar-apr/postural-orthostatic-tachycardia-syndrome

  Pharmacologic treatments can be added to address POTS symptoms when nonpharmacologic treatments are insufficient. Medication can be used to expand blood volume, reduce heart rate, induce peripheral vasoconstriction, and for sympatholysis. Medications can also be used to target the comorbidities of POTS; these are symptom driven. […] Fludrocortisone is a mineralocorticoid that increases blood volume through activation of the renin-aldosterone system. Doses up to 0.2 mg/day do not suppress the hypothalamic-pituitary axis and are well tolerated. Desmopressin (DDAVP) is an antidiuretic hormone that promotes free water retention. Electrolyte levels should be monitored with chronic use to avoid hyponatremia, which can occur with high-volume free-water intake. Midodrine is a potent vasoconstrictor that has several actions, including increasing blood pressure, venous return, cardiac preload, and stroke volume. Midodrine should be taken only when awake, however, because it can cause supine hypertension. Beta blockers, most commonly metoprolol in children and adolescents, are used to decrease heart rate and can be of great benefit for those with symptomatic palpitations. However, metoprolol can cause exercise intolerance and hypotension.

• #67 Postural Orthostatic Tachycardia Syndrome (POTS): Evaluation and Management | British Journal of Medical Practitioners

  https://www.bjmp.org/content/postural-orthostatic-tachycardia-syndrome-pots-evaluation-and-management

  The goal of pharmacotherapy in the treatment of POTS is to ameliorate the symptoms of POTS and thus maintain the functional capacity. Currently no drug is US FDA approved for the treatment of POTS. All pharmacology is inherently off-label. […] Majority of the evidence for the use of different pharmacological agents in the management of POTS is based on some small randomised, observational and retrospective single center studies. In clinical practice most patients are treated with a single agent and second medication from different class with a different mechanism of action is added in case of treatment failure. Resistant cases are often treated with polypharmacy. […] Fludrocortisone, a potent mineralocorticoid resulting in sodium retention, augmented fluid volume, and sensitized peripheral alpha adrenergic receptors. The effects are more pronounced in the younger population. Starting dose is 0.1-0.2 mg daily with a maximum dose of 0.4 mg. Common side effects include electrolyte imbalance and hypertension. In a study of 11 female POTS patients, fludricortisone alone or in combination with bisoprolol was associated with improvement in symptoms. Midodrine is an alpha-1 adrenoreceptor agonist and causes both arterial and venous vasoconstriction. It is commonly used as add on therapy and with starting dose at 5 mg orally three times a day. In our clinical experience we advise patients to take their first dose of midodrine 15 minutes prior to getting out of bed. An additional 5mg dose can be used for breakthrough symptoms. Midodrine is usually well tolerated with the most common complaints being nausea, goose bumps, and scalp pruritus.

• #68 Postural orthostatic tachycardia syndrome – Wikipedia

  https://en.wikipedia.org/wiki/Postural_orthostatic_tachycardia_syndrome

  Pyridostigmine, an acetylcholinesterase inhibitor and parasympathomimetic, has been reported to restrain heart rate and improve chronic symptoms in approximately half of people. However, it may cause GI side effects that limit its use in around 20% of its patient population. […] The selective 1-adrenergic receptor agonist phenylephrine has been used successfully to enhance venous return and stroke volume in some people with POTS. However, this medication may be hampered by poor oral bioavailability. […] Indirectly acting sympathomimetics, like the norepinephrine releasing agents ephedrine and pseudoephedrine and the norepinephrine-dopamine reuptake inhibitors methylphenidate and bupropion, have also been used in the treatment of POTS. […] The norepinephrine prodrug droxidopa has been used as well.

• #69 Postural orthostatic tachycardia syndrome – Wikipedia

  https://en.wikipedia.org/wiki/Postural_orthostatic_tachycardia_syndrome

  Pyridostigmine, an acetylcholinesterase inhibitor and parasympathomimetic, has been reported to restrain heart rate and improve chronic symptoms in approximately half of people. However, it may cause GI side effects that limit its use in around 20% of its patient population. […] The selective 1-adrenergic receptor agonist phenylephrine has been used successfully to enhance venous return and stroke volume in some people with POTS. However, this medication may be hampered by poor oral bioavailability. […] Indirectly acting sympathomimetics, like the norepinephrine releasing agents ephedrine and pseudoephedrine and the norepinephrine-dopamine reuptake inhibitors methylphenidate and bupropion, have also been used in the treatment of POTS. […] The norepinephrine prodrug droxidopa has been used as well.

• #70 Choices and Challenges With Drug Therapy in Postural Orthostatic Tachycardia Syndrome: A Systematic Review

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10259876/

  The literature on pharmacologic treatments for postural orthostatic tachycardia syndrome (POTS) is inconsistent and unstandardized. Therefore, we aimed to evaluate choices in pharmacologic treatment options for POTS and the challenges encountered in the studies. Results demonstrated that pharmacologic treatment options for POTS were effective in reducing symptoms of POTS, but most of the studies were underpowered. Several were terminated due to various reasons. Midodrine ivabradine, bisoprolol, fludrocortisone, droxidopa, desmopressin, propranolol, modafinil, methylphenidate, and melatonin have been studied with positive impact but sample sizes that were low in the range of 10-50 subjects. Therefore, we concluded the treatment options effectively improve symptoms of POTS and increase orthostatic tolerance, but more evidence is needed as most studies had a low sample size and thus are underpowered. Pharmacologic therapies have been explored in minimizing symptoms and increasing functional ability in POTS patients. Treatment targets have focused on reducing heart rate (beta-blockers), increasing cardiac output (increase in salt intake), or increasing blood pressure (midodrine). The therapies are based on the hypothesis that affecting the said parameters will reduce symptom burden and are aimed at managing symptoms such as lightheadedness, dizziness, and rapid heartbeat that occur when standing up. Patients with POTS may respond differently to therapy depending on their intensity, underlying disorders, and other medical conditions. The treatment is directed at symptom burden which may or may not include dizziness/lightheadedness, fainting, rapid heartbeat/palpitations, chest pain/discomfort, shortness of breath, headaches, fatigue/weakness, nausea, abdominal pain, brain fog/difficulty concentrating, blurred vision, sweating, shakiness/tremors, insomnia/disrupted sleep, exercise intolerance. The reduction in symptom burden may be due to the ability of pharmacologic treatments to regulate the autonomic nervous system, which controls many of the body’s involuntary functions, including heart rate, blood pressure, and digestion. By regulating the autonomic nervous system, pharmacologic treatments can help improve blood flow and reduce symptoms such as lightheadedness, dizziness, and fatigue, common in patients with POTS. Patients and doctors alike face formidable obstacles in dealing with postural tachycardia syndrome. Because POTS may profoundly influence patients’ quality of life, there is an urgent need for better treatment alternatives. Patients with POTS might expect reduced symptoms and enhanced functional ability with the help of pharmacologic therapies. However, patient-specific treatment plans that account for comorbidities, drug tolerance, and other factors are necessary. Prescribing drugs to people with POTS might further complicate care if practitioners aren’t aware of possible side effects and drug interactions. To get the best results from therapy, it’s important to include non-pharmacologic measures alongside drug therapy.

• #71 Postural orthostatic tachycardia syndrome – Wikipedia

  https://en.wikipedia.org/wiki/Postural_orthostatic_tachycardia_syndrome

  Pyridostigmine, an acetylcholinesterase inhibitor and parasympathomimetic, has been reported to restrain heart rate and improve chronic symptoms in approximately half of people. However, it may cause GI side effects that limit its use in around 20% of its patient population. […] The selective 1-adrenergic receptor agonist phenylephrine has been used successfully to enhance venous return and stroke volume in some people with POTS. However, this medication may be hampered by poor oral bioavailability. […] Indirectly acting sympathomimetics, like the norepinephrine releasing agents ephedrine and pseudoephedrine and the norepinephrine-dopamine reuptake inhibitors methylphenidate and bupropion, have also been used in the treatment of POTS. […] The norepinephrine prodrug droxidopa has been used as well.

• #72 Choices and Challenges With Drug Therapy in Postural Orthostatic Tachycardia Syndrome: A Systematic Review

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10259876/

  The literature on pharmacologic treatments for postural orthostatic tachycardia syndrome (POTS) is inconsistent and unstandardized. Therefore, we aimed to evaluate choices in pharmacologic treatment options for POTS and the challenges encountered in the studies. Results demonstrated that pharmacologic treatment options for POTS were effective in reducing symptoms of POTS, but most of the studies were underpowered. Several were terminated due to various reasons. Midodrine ivabradine, bisoprolol, fludrocortisone, droxidopa, desmopressin, propranolol, modafinil, methylphenidate, and melatonin have been studied with positive impact but sample sizes that were low in the range of 10-50 subjects. Therefore, we concluded the treatment options effectively improve symptoms of POTS and increase orthostatic tolerance, but more evidence is needed as most studies had a low sample size and thus are underpowered. Pharmacologic therapies have been explored in minimizing symptoms and increasing functional ability in POTS patients. Treatment targets have focused on reducing heart rate (beta-blockers), increasing cardiac output (increase in salt intake), or increasing blood pressure (midodrine). The therapies are based on the hypothesis that affecting the said parameters will reduce symptom burden and are aimed at managing symptoms such as lightheadedness, dizziness, and rapid heartbeat that occur when standing up. Patients with POTS may respond differently to therapy depending on their intensity, underlying disorders, and other medical conditions. The treatment is directed at symptom burden which may or may not include dizziness/lightheadedness, fainting, rapid heartbeat/palpitations, chest pain/discomfort, shortness of breath, headaches, fatigue/weakness, nausea, abdominal pain, brain fog/difficulty concentrating, blurred vision, sweating, shakiness/tremors, insomnia/disrupted sleep, exercise intolerance. The reduction in symptom burden may be due to the ability of pharmacologic treatments to regulate the autonomic nervous system, which controls many of the body’s involuntary functions, including heart rate, blood pressure, and digestion. By regulating the autonomic nervous system, pharmacologic treatments can help improve blood flow and reduce symptoms such as lightheadedness, dizziness, and fatigue, common in patients with POTS. Patients and doctors alike face formidable obstacles in dealing with postural tachycardia syndrome. Because POTS may profoundly influence patients’ quality of life, there is an urgent need for better treatment alternatives. Patients with POTS might expect reduced symptoms and enhanced functional ability with the help of pharmacologic therapies. However, patient-specific treatment plans that account for comorbidities, drug tolerance, and other factors are necessary. Prescribing drugs to people with POTS might further complicate care if practitioners aren’t aware of possible side effects and drug interactions. To get the best results from therapy, it’s important to include non-pharmacologic measures alongside drug therapy.

• #73 Postural Orthostatic Tachycardia Syndrome – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK541074/

  Clonidine and alpha-methyldopa are central-acting alpha-2 agonist sympatholytics that may be beneficial in hyperadrenergic subtypes with hypertension as a predominant symptom. […] Beta-blockers (propranolol, metoprolol) may reduce upright tachycardia without significant hemodynamic changes. […] Pyridostigmine is an acetylcholinesterase inhibitor that increases acetylcholine levels in the autonomic ganglia. […] Ivabradine is FDA-approved for heart failure, but it could be helpful for patients with POTS. […] Generally, medications exacerbating specific symptoms such as tachycardia or worsening orthostatic intolerance should be avoided; in specific cases, it may be beneficial in accordance with the patients history and presentation.

• #74 Postural Orthostatic Tachycardia Syndrome – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK541074/

  Clonidine and alpha-methyldopa are central-acting alpha-2 agonist sympatholytics that may be beneficial in hyperadrenergic subtypes with hypertension as a predominant symptom. […] Beta-blockers (propranolol, metoprolol) may reduce upright tachycardia without significant hemodynamic changes. […] Pyridostigmine is an acetylcholinesterase inhibitor that increases acetylcholine levels in the autonomic ganglia. […] Ivabradine is FDA-approved for heart failure, but it could be helpful for patients with POTS. […] Generally, medications exacerbating specific symptoms such as tachycardia or worsening orthostatic intolerance should be avoided; in specific cases, it may be beneficial in accordance with the patients history and presentation.

• #75 Management of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia and Vasovagal Syncope | AER Journal

  https://www.aerjournal.com/articles/management-postural-tachycardia-syndrome-inappropriate-sinus-tachycardia-and-vasovagal?language_content_entity=en

  Patients should engage in a regular, structured, graduated, supervised exercise program featuring aerobic reconditioning with some resistance training of the thighs, starting with non-upright exercises. […] Fludrocortisone might be useful in the treatment of POTS through enhanced sodium retention and plasma volume expansion, although its effectiveness for POTS has not been tested in randomised clinical trials. […] Midodrine is a prodrug whose metabolite is a peripheral alpha-1 adrenergic receptor agonist that constricts both veins and arteries. It significantly reduces orthostatic tachycardia. […] Low-dose oral propranolol (10-20 mg) is effective at lowering standing heart rate and may improve symptoms in POTS patients acutely, while higher doses are less effective. […] Ivabradine slows sinus rates without impacting blood pressure. About 60 % of POTS patients treated with ivabradine in an open-label study improved.

• #76 Medications for POTS | Standing Up To POTS

  https://www.standinguptopots.org/resources/medicine

  There is currently no cure for postural orthostatic tachycardia syndrome (POTS). These medications are prescribed off-label; meaning that they were designed for other disorders but have not been approved for POTS by the U.S. Food and Drug Administration. They may, however, help alleviate POTS symptoms and often require trial and error to find the best combination for individual patients. Here are some of the more common medications used to treat POTS symptoms. […] Beta-blockers are especially recommended in hyperadrenergic subtype associated with sinus tachycardia 120 bpm on standing (Fedorowski 2018). […] Effective in people with low blood pressure or when beta-blockers are not well tolerated (Fedorowski 2018). […] This calcium channel blockers can be effective for those with higher blood pressure, migraine, and chest pain (Fedorowski 2018).

• #77 Postural Orthostatic Tachycardia Syndrome

  https://practicalneurology.com/articles/2020-mar-apr/postural-orthostatic-tachycardia-syndrome

  Pharmacologic treatments can be added to address POTS symptoms when nonpharmacologic treatments are insufficient. Medication can be used to expand blood volume, reduce heart rate, induce peripheral vasoconstriction, and for sympatholysis. Medications can also be used to target the comorbidities of POTS; these are symptom driven. […] Fludrocortisone is a mineralocorticoid that increases blood volume through activation of the renin-aldosterone system. Doses up to 0.2 mg/day do not suppress the hypothalamic-pituitary axis and are well tolerated. Desmopressin (DDAVP) is an antidiuretic hormone that promotes free water retention. Electrolyte levels should be monitored with chronic use to avoid hyponatremia, which can occur with high-volume free-water intake. Midodrine is a potent vasoconstrictor that has several actions, including increasing blood pressure, venous return, cardiac preload, and stroke volume. Midodrine should be taken only when awake, however, because it can cause supine hypertension. Beta blockers, most commonly metoprolol in children and adolescents, are used to decrease heart rate and can be of great benefit for those with symptomatic palpitations. However, metoprolol can cause exercise intolerance and hypotension.

• #78 Postural Orthostatic Tachycardia Syndrome – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK541074/

  Clonidine and alpha-methyldopa are central-acting alpha-2 agonist sympatholytics that may be beneficial in hyperadrenergic subtypes with hypertension as a predominant symptom. […] Beta-blockers (propranolol, metoprolol) may reduce upright tachycardia without significant hemodynamic changes. […] Pyridostigmine is an acetylcholinesterase inhibitor that increases acetylcholine levels in the autonomic ganglia. […] Ivabradine is FDA-approved for heart failure, but it could be helpful for patients with POTS. […] Generally, medications exacerbating specific symptoms such as tachycardia or worsening orthostatic intolerance should be avoided; in specific cases, it may be beneficial in accordance with the patients history and presentation.

• #79 Postural orthostatic tachycardia syndrome – Wikipedia

  https://en.wikipedia.org/wiki/Postural_orthostatic_tachycardia_syndrome

  Fludrocortisone, a mineralocorticoid, may be used to enhance sodium retention and blood volume, which may be beneficial not only by augmenting sympathetically mediated vasoconstriction, but also because a large subset of POTS patients appear to have low absolute blood volume. […] While people with POTS typically have normal or even elevated arterial blood pressure, the neuropathic form of POTS is presumed to constitute a selective sympathetic venous denervation. In these patients the selective 1-adrenergic receptor agonist midodrine may increase venous return, enhance stroke volume, and improve symptoms. […] Sinus node blocker ivabradine can successfully restrain heart rate in POTS without affecting blood pressure, demonstrated in approximately 60% of people with POTS treated in an open-label trial of ivabradine experienced symptom improvement.

• #80 POTS-associated Conditions and Management Strategies | USC Journal

  https://www.uscjournal.com/articles/narrative-review-postural-orthostatic-tachycardia-syndrome-associated-conditions-and?language_content_entity=en

  Ivabradine, a drug approved by the FDA for symptomatic heart failure with reduced ejection fraction, is being increasingly used in POTS patients due to its cardiac selectivity. […] Pyridostigmine acts to inhibit acetylcholinesterase, increasing the availability of acetylcholine at ganglionic nicotinic receptors and postganglionic muscarinic receptors. […] Medications That Target Hypovolemia […] In addition to salt supplementation, fludrocortisone, a glucocorticoid that acts similarly to aldosterone, has shown efficacy in improving POTS symptoms. […] Therapies directed towards mast cell activation may also provide benefit in patients with POTS, particularly those with suspected coexisting MCAS. […] For patients with autoimmune-associated POTS, particularly those diagnosed with SFN, IVIG and plasmapheresis have demonstrated improvement in symptoms.

• #81 Postural orthostatic tachycardia syndrome – Wikipedia

  https://en.wikipedia.org/wiki/Postural_orthostatic_tachycardia_syndrome

  Fludrocortisone, a mineralocorticoid, may be used to enhance sodium retention and blood volume, which may be beneficial not only by augmenting sympathetically mediated vasoconstriction, but also because a large subset of POTS patients appear to have low absolute blood volume. […] While people with POTS typically have normal or even elevated arterial blood pressure, the neuropathic form of POTS is presumed to constitute a selective sympathetic venous denervation. In these patients the selective 1-adrenergic receptor agonist midodrine may increase venous return, enhance stroke volume, and improve symptoms. […] Sinus node blocker ivabradine can successfully restrain heart rate in POTS without affecting blood pressure, demonstrated in approximately 60% of people with POTS treated in an open-label trial of ivabradine experienced symptom improvement.

• #82 Medications for POTS | Standing Up To POTS

  https://www.standinguptopots.org/resources/medicine

  There is currently no cure for postural orthostatic tachycardia syndrome (POTS). These medications are prescribed off-label; meaning that they were designed for other disorders but have not been approved for POTS by the U.S. Food and Drug Administration. They may, however, help alleviate POTS symptoms and often require trial and error to find the best combination for individual patients. Here are some of the more common medications used to treat POTS symptoms. […] Beta-blockers are especially recommended in hyperadrenergic subtype associated with sinus tachycardia 120 bpm on standing (Fedorowski 2018). […] Effective in people with low blood pressure or when beta-blockers are not well tolerated (Fedorowski 2018). […] This calcium channel blockers can be effective for those with higher blood pressure, migraine, and chest pain (Fedorowski 2018).

• #83 POTS-associated Conditions and Management Strategies | USC Journal

  https://www.uscjournal.com/articles/narrative-review-postural-orthostatic-tachycardia-syndrome-associated-conditions-and?language_content_entity=en

  Ivabradine, a drug approved by the FDA for symptomatic heart failure with reduced ejection fraction, is being increasingly used in POTS patients due to its cardiac selectivity. […] Pyridostigmine acts to inhibit acetylcholinesterase, increasing the availability of acetylcholine at ganglionic nicotinic receptors and postganglionic muscarinic receptors. […] Medications That Target Hypovolemia […] In addition to salt supplementation, fludrocortisone, a glucocorticoid that acts similarly to aldosterone, has shown efficacy in improving POTS symptoms. […] Therapies directed towards mast cell activation may also provide benefit in patients with POTS, particularly those with suspected coexisting MCAS. […] For patients with autoimmune-associated POTS, particularly those diagnosed with SFN, IVIG and plasmapheresis have demonstrated improvement in symptoms.

• #84 Postural Orthostatic Tachycardia Syndrome – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK541074/

  Clonidine and alpha-methyldopa are central-acting alpha-2 agonist sympatholytics that may be beneficial in hyperadrenergic subtypes with hypertension as a predominant symptom. […] Beta-blockers (propranolol, metoprolol) may reduce upright tachycardia without significant hemodynamic changes. […] Pyridostigmine is an acetylcholinesterase inhibitor that increases acetylcholine levels in the autonomic ganglia. […] Ivabradine is FDA-approved for heart failure, but it could be helpful for patients with POTS. […] Generally, medications exacerbating specific symptoms such as tachycardia or worsening orthostatic intolerance should be avoided; in specific cases, it may be beneficial in accordance with the patients history and presentation.

• #85 Postural orthostatic tachycardia syndrome – Wikipedia

  https://en.wikipedia.org/wiki/Postural_orthostatic_tachycardia_syndrome

  Pyridostigmine, an acetylcholinesterase inhibitor and parasympathomimetic, has been reported to restrain heart rate and improve chronic symptoms in approximately half of people. However, it may cause GI side effects that limit its use in around 20% of its patient population. […] The selective 1-adrenergic receptor agonist phenylephrine has been used successfully to enhance venous return and stroke volume in some people with POTS. However, this medication may be hampered by poor oral bioavailability. […] Indirectly acting sympathomimetics, like the norepinephrine releasing agents ephedrine and pseudoephedrine and the norepinephrine-dopamine reuptake inhibitors methylphenidate and bupropion, have also been used in the treatment of POTS. […] The norepinephrine prodrug droxidopa has been used as well.

• #86 Medications for POTS | Standing Up To POTS

  https://www.standinguptopots.org/resources/medicine

  Generally recommended for those with hyperadrenergic POTS and hypertensive tendency on standing (Fedorowski 2018). […] Particularly helpful in patients with suspected autonomic neuropathy, gastrointestinal dysfunction and non-specific muscle weakness (Fedorowski 2018). […] Recommended for the hypovolemic subtype of POTS and those with low blood pressure. […] Effective in hypovolemic subtype of POTS and low blood pressure phenotype with pronounced orthostatic intolerance (Fedorowski 2018). […] This medication is a synthetic version of antidiuretic hormone, and helps the body retain water which can increase blood pressure. […] In acute decompensated POTS, IV fluids can alleviate short-term symptoms (Fedorowski 2018). […] These are the same medications that can be used for individuals who have Attention Deficit Disorder. For POTS, they are used for those experiencing significant fatigue and brain fog.

• #87 Postural orthostatic tachycardia syndrome – Wikipedia

  https://en.wikipedia.org/wiki/Postural_orthostatic_tachycardia_syndrome

  Pyridostigmine, an acetylcholinesterase inhibitor and parasympathomimetic, has been reported to restrain heart rate and improve chronic symptoms in approximately half of people. However, it may cause GI side effects that limit its use in around 20% of its patient population. […] The selective 1-adrenergic receptor agonist phenylephrine has been used successfully to enhance venous return and stroke volume in some people with POTS. However, this medication may be hampered by poor oral bioavailability. […] Indirectly acting sympathomimetics, like the norepinephrine releasing agents ephedrine and pseudoephedrine and the norepinephrine-dopamine reuptake inhibitors methylphenidate and bupropion, have also been used in the treatment of POTS. […] The norepinephrine prodrug droxidopa has been used as well.

• #88 Postural Orthostatic Tachycardia Syndrome (POTS): Evaluation and Management | British Journal of Medical Practitioners

  https://www.bjmp.org/content/postural-orthostatic-tachycardia-syndrome-pots-evaluation-and-management

  Pyridostigmine is an acetylcholinesterase inhibitor that facilitates sympathetic and parasympathetic ganglionic neural transmission. In our single center experience of 203 patients of POTS treated with pyridostigmine; improved symptoms of orthostatic intolerance were seen in 88 of 203 (43%) of total patients or 88 of 172 (51%) who were able to tolerate the drug. Fatigue (55%), palpitations (60%), presyncope (60%), and syncope (48%) were the most common symptoms that improved with pyridostigmine. […] Severely affected and refractory patients may benefit from erythropoietin (EPO) therapy. EPO increases red cell mass, central blood volume and augments response of blood vessels to the angiotensin-II and thus causes vasoconstriction. These effects are quite useful in the treatment of orthostatic disorders.

• #89 Postural Orthostatic Tachycardia Syndrome – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK541074/

  Clonidine and alpha-methyldopa are central-acting alpha-2 agonist sympatholytics that may be beneficial in hyperadrenergic subtypes with hypertension as a predominant symptom. […] Beta-blockers (propranolol, metoprolol) may reduce upright tachycardia without significant hemodynamic changes. […] Pyridostigmine is an acetylcholinesterase inhibitor that increases acetylcholine levels in the autonomic ganglia. […] Ivabradine is FDA-approved for heart failure, but it could be helpful for patients with POTS. […] Generally, medications exacerbating specific symptoms such as tachycardia or worsening orthostatic intolerance should be avoided; in specific cases, it may be beneficial in accordance with the patients history and presentation.

• #90 Medication Overview | PoTS UK

  https://www.potsuk.org/managingpots/medication-2/

  SNRIs may worsen tachycardia in patients with PoTS. […] Fludrocortisione is a mineralocorticoid, licensed for use in orthostatic hypotension, the action of which is to retain salt and water. […] Desmopressin is a hormone that reduces urine production, promotes fluid retention and therefore decreases heart rate, improving symptoms of PoTS. […] Clonidine or Methyldopa may be used in Hyperadrenergic PoTS. […] Modafinil is a stimulant normally used in some sleep disorders, and may improve alertness and decrease mental clouding in those with PoTS.

• #91 Postural Orthostatic Tachycardia Syndrome – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK541074/

  Clonidine and alpha-methyldopa are central-acting alpha-2 agonist sympatholytics that may be beneficial in hyperadrenergic subtypes with hypertension as a predominant symptom. […] Beta-blockers (propranolol, metoprolol) may reduce upright tachycardia without significant hemodynamic changes. […] Pyridostigmine is an acetylcholinesterase inhibitor that increases acetylcholine levels in the autonomic ganglia. […] Ivabradine is FDA-approved for heart failure, but it could be helpful for patients with POTS. […] Generally, medications exacerbating specific symptoms such as tachycardia or worsening orthostatic intolerance should be avoided; in specific cases, it may be beneficial in accordance with the patients history and presentation.

• #92 Postural Orthostatic Tachycardia Syndrome (POTS): Evaluation and Management | British Journal of Medical Practitioners

  https://www.bjmp.org/content/postural-orthostatic-tachycardia-syndrome-pots-evaluation-and-management

  Beta blocker therapy such as metoprolol tartrate may be beneficial in adolescent type POTS patients. In a single center retrospective study of 121 patients with possible POTS, written survey at follow-up were used to evaluate response to therapy with beta-blockers and midodrine. […] Octreotide is a somatostatin analogue with potent vasoconstrictive effects and is useful in the treatment of orthostatic disorders. In patients with resistant POTS, octreotide may be a useful as add on therapy. […] Agents that block the release or effect of norepinephrine (noradrenaline) are very effective for hyperadrenergic type POTS patients. We use clonidine starting at 0.1 mg orally twice daily and titrating up as needed. […] Treatment of secondary POTS should focus primarily on the underlying disorder to the greatest extent possible.

• #93 Postural Orthostatic Tachycardia Syndrome (POTS): Evaluation and Management | British Journal of Medical Practitioners

  https://www.bjmp.org/content/postural-orthostatic-tachycardia-syndrome-pots-evaluation-and-management

  Patients may continue to be symptomatic despite dual-therapy as outlined above. In this population we add a serotonin reuptake inhibitor (SSRI) or norepinephrine reuptake inhibitor (SNRI). SSRI therapy has been found to be helpful in the prevention of neurocardiogenic syncope. However, SNRI therapy is more useful in the treatment of POTS. Usually, we use bupropion XL beginning with 150 mg orally daily titratable to 300 mg daily if necessary. […] The most effective SSRI therapies combine serotonin and norepinephrine reuptake inhibition (venlafaxine and duloxetine). The agents are usually well tolerated with the most common side effects being gastrointestinal upset, tremor, sleep disturbance, and less commonly agitation and sexual dysfunction. Bupropion and SSRI therapy can be combined to achieve a similar effect.

• #94 Postural Orthostatic Tachycardia Syndrome (POTS): Evaluation and Management | British Journal of Medical Practitioners

  https://www.bjmp.org/content/postural-orthostatic-tachycardia-syndrome-pots-evaluation-and-management

  Patients may continue to be symptomatic despite dual-therapy as outlined above. In this population we add a serotonin reuptake inhibitor (SSRI) or norepinephrine reuptake inhibitor (SNRI). SSRI therapy has been found to be helpful in the prevention of neurocardiogenic syncope. However, SNRI therapy is more useful in the treatment of POTS. Usually, we use bupropion XL beginning with 150 mg orally daily titratable to 300 mg daily if necessary. […] The most effective SSRI therapies combine serotonin and norepinephrine reuptake inhibition (venlafaxine and duloxetine). The agents are usually well tolerated with the most common side effects being gastrointestinal upset, tremor, sleep disturbance, and less commonly agitation and sexual dysfunction. Bupropion and SSRI therapy can be combined to achieve a similar effect.

• #95 Postural Orthostatic Tachycardia Syndrome (POTS): Evaluation and Management | British Journal of Medical Practitioners

  https://www.bjmp.org/content/postural-orthostatic-tachycardia-syndrome-pots-evaluation-and-management

  Patients may continue to be symptomatic despite dual-therapy as outlined above. In this population we add a serotonin reuptake inhibitor (SSRI) or norepinephrine reuptake inhibitor (SNRI). SSRI therapy has been found to be helpful in the prevention of neurocardiogenic syncope. However, SNRI therapy is more useful in the treatment of POTS. Usually, we use bupropion XL beginning with 150 mg orally daily titratable to 300 mg daily if necessary. […] The most effective SSRI therapies combine serotonin and norepinephrine reuptake inhibition (venlafaxine and duloxetine). The agents are usually well tolerated with the most common side effects being gastrointestinal upset, tremor, sleep disturbance, and less commonly agitation and sexual dysfunction. Bupropion and SSRI therapy can be combined to achieve a similar effect.

• #96 Medications for POTS | Standing Up To POTS

  https://www.standinguptopots.org/resources/medicine

  This medication reduces pain and fights inflammation and has been used to treat a wide variety of disorders, including POTS. […] In cases where the patient presents with signs of mast cell activation syndrome (MCAS) – facial flushing, hives, history of anaphylaxis, etc. – having the patient try a cocktail of antihistamines could be helpful. […] These medications can help people with POTS who are prone to fainting by raising the blood pressure and modifying the brains response to low blood pressure signals. […] This antidepressant can be used as an adjuvant treatment for chronic neuropathic pain that is common in POTS and is helpful in 25% of cases (Moore et al. 2015). […] Selective Norepinephrine Reuptake Inhibitors can be detrimental to POTS patients. Avoid Desvenlafaxine (Pristiq), Duloxetine (Cymbalta), and Venlafaxine (Effexor) which fall into this SNRI category as they increase norepinephrine in the synapse and can increase sympathetic drive, already a problem for many POTS patients.

• #97 Medication Overview | PoTS UK

  https://www.potsuk.org/managingpots/medication-2/

  SNRIs may worsen tachycardia in patients with PoTS. […] Fludrocortisione is a mineralocorticoid, licensed for use in orthostatic hypotension, the action of which is to retain salt and water. […] Desmopressin is a hormone that reduces urine production, promotes fluid retention and therefore decreases heart rate, improving symptoms of PoTS. […] Clonidine or Methyldopa may be used in Hyperadrenergic PoTS. […] Modafinil is a stimulant normally used in some sleep disorders, and may improve alertness and decrease mental clouding in those with PoTS.

• #98 Medication Overview | PoTS UK

  https://www.potsuk.org/managingpots/medication-2/

  SNRIs may worsen tachycardia in patients with PoTS. […] Fludrocortisione is a mineralocorticoid, licensed for use in orthostatic hypotension, the action of which is to retain salt and water. […] Desmopressin is a hormone that reduces urine production, promotes fluid retention and therefore decreases heart rate, improving symptoms of PoTS. […] Clonidine or Methyldopa may be used in Hyperadrenergic PoTS. […] Modafinil is a stimulant normally used in some sleep disorders, and may improve alertness and decrease mental clouding in those with PoTS.

• #99 Postural Orthostatic Tachycardia Syndrome (POTS): Evaluation and Management | British Journal of Medical Practitioners

  https://www.bjmp.org/content/postural-orthostatic-tachycardia-syndrome-pots-evaluation-and-management

  Beta blocker therapy such as metoprolol tartrate may be beneficial in adolescent type POTS patients. In a single center retrospective study of 121 patients with possible POTS, written survey at follow-up were used to evaluate response to therapy with beta-blockers and midodrine. […] Octreotide is a somatostatin analogue with potent vasoconstrictive effects and is useful in the treatment of orthostatic disorders. In patients with resistant POTS, octreotide may be a useful as add on therapy. […] Agents that block the release or effect of norepinephrine (noradrenaline) are very effective for hyperadrenergic type POTS patients. We use clonidine starting at 0.1 mg orally twice daily and titrating up as needed. […] Treatment of secondary POTS should focus primarily on the underlying disorder to the greatest extent possible.

• #100 Postural Orthostatic Tachycardia Syndrome (POTS): Evaluation and Management | British Journal of Medical Practitioners

  https://www.bjmp.org/content/postural-orthostatic-tachycardia-syndrome-pots-evaluation-and-management

  Pyridostigmine is an acetylcholinesterase inhibitor that facilitates sympathetic and parasympathetic ganglionic neural transmission. In our single center experience of 203 patients of POTS treated with pyridostigmine; improved symptoms of orthostatic intolerance were seen in 88 of 203 (43%) of total patients or 88 of 172 (51%) who were able to tolerate the drug. Fatigue (55%), palpitations (60%), presyncope (60%), and syncope (48%) were the most common symptoms that improved with pyridostigmine. […] Severely affected and refractory patients may benefit from erythropoietin (EPO) therapy. EPO increases red cell mass, central blood volume and augments response of blood vessels to the angiotensin-II and thus causes vasoconstriction. These effects are quite useful in the treatment of orthostatic disorders.

• #101 POTS-associated Conditions and Management Strategies | USC Journal

  https://www.uscjournal.com/articles/narrative-review-postural-orthostatic-tachycardia-syndrome-associated-conditions-and?language_content_entity=en

  Ivabradine, a drug approved by the FDA for symptomatic heart failure with reduced ejection fraction, is being increasingly used in POTS patients due to its cardiac selectivity. […] Pyridostigmine acts to inhibit acetylcholinesterase, increasing the availability of acetylcholine at ganglionic nicotinic receptors and postganglionic muscarinic receptors. […] Medications That Target Hypovolemia […] In addition to salt supplementation, fludrocortisone, a glucocorticoid that acts similarly to aldosterone, has shown efficacy in improving POTS symptoms. […] Therapies directed towards mast cell activation may also provide benefit in patients with POTS, particularly those with suspected coexisting MCAS. […] For patients with autoimmune-associated POTS, particularly those diagnosed with SFN, IVIG and plasmapheresis have demonstrated improvement in symptoms.

• #102 Medications for POTS | Standing Up To POTS

  https://www.standinguptopots.org/resources/medicine

  This medication reduces pain and fights inflammation and has been used to treat a wide variety of disorders, including POTS. […] In cases where the patient presents with signs of mast cell activation syndrome (MCAS) – facial flushing, hives, history of anaphylaxis, etc. – having the patient try a cocktail of antihistamines could be helpful. […] These medications can help people with POTS who are prone to fainting by raising the blood pressure and modifying the brains response to low blood pressure signals. […] This antidepressant can be used as an adjuvant treatment for chronic neuropathic pain that is common in POTS and is helpful in 25% of cases (Moore et al. 2015). […] Selective Norepinephrine Reuptake Inhibitors can be detrimental to POTS patients. Avoid Desvenlafaxine (Pristiq), Duloxetine (Cymbalta), and Venlafaxine (Effexor) which fall into this SNRI category as they increase norepinephrine in the synapse and can increase sympathetic drive, already a problem for many POTS patients.

• #103 Medications for POTS | Standing Up To POTS

  https://www.standinguptopots.org/resources/medicine

  This medication reduces pain and fights inflammation and has been used to treat a wide variety of disorders, including POTS. […] In cases where the patient presents with signs of mast cell activation syndrome (MCAS) – facial flushing, hives, history of anaphylaxis, etc. – having the patient try a cocktail of antihistamines could be helpful. […] These medications can help people with POTS who are prone to fainting by raising the blood pressure and modifying the brains response to low blood pressure signals. […] This antidepressant can be used as an adjuvant treatment for chronic neuropathic pain that is common in POTS and is helpful in 25% of cases (Moore et al. 2015). […] Selective Norepinephrine Reuptake Inhibitors can be detrimental to POTS patients. Avoid Desvenlafaxine (Pristiq), Duloxetine (Cymbalta), and Venlafaxine (Effexor) which fall into this SNRI category as they increase norepinephrine in the synapse and can increase sympathetic drive, already a problem for many POTS patients.

• #104 POTS-associated Conditions and Management Strategies | USC Journal

  https://www.uscjournal.com/articles/narrative-review-postural-orthostatic-tachycardia-syndrome-associated-conditions-and?language_content_entity=en

  Ivabradine, a drug approved by the FDA for symptomatic heart failure with reduced ejection fraction, is being increasingly used in POTS patients due to its cardiac selectivity. […] Pyridostigmine acts to inhibit acetylcholinesterase, increasing the availability of acetylcholine at ganglionic nicotinic receptors and postganglionic muscarinic receptors. […] Medications That Target Hypovolemia […] In addition to salt supplementation, fludrocortisone, a glucocorticoid that acts similarly to aldosterone, has shown efficacy in improving POTS symptoms. […] Therapies directed towards mast cell activation may also provide benefit in patients with POTS, particularly those with suspected coexisting MCAS. […] For patients with autoimmune-associated POTS, particularly those diagnosed with SFN, IVIG and plasmapheresis have demonstrated improvement in symptoms.

• #105 Autoimmunity and postural orthostatic tachycardia syndrome: Implications in diagnosis and management | Cleveland Clinic Journal of Medicine

  https://www.ccjm.org/content/90/7/439

  Postural orthostatic tachycardia syndrome (POTS) sustained tachycardia upon standing without orthostatic hypotension can be diagnosed clinically without an extensive diagnostic evaluation unless certain atypical features suggest an alternative diagnosis. […] However, immunotherapies are not currently recommended for POTS, although clinical trials are underway to clarify their utility. […] Nonpharmacologic strategies should be the first intervention and include the following: volume expansion by increasing oral intake of water to 2 to 3 L/day and salt to 10 to 12 g/day, compression garments including abdominal and thigh compression, sleeping with the head of the bed elevated 4 to 6 inches, removing exacerbating factors such as large meals and medications, a graded exercise program featuring endurance reconditioning and lower-body resistance training, and behavioral and cognitive therapy for patients with significant anxiety, somatic hypervigilance, or catastrophizing behaviors. […] There are not enough data currently to warrant treating POTS with immunosuppressive therapies. Important clinical trials are underway to explore this treatment approach further.

• #106 Management of POTS due to Long COVID | AAFP

  https://www.aafp.org/pubs/afp/afp-community-blog/entry/management-of-pots-due-to-long-covid.html

  Forms of cardiac dysautonomia associated with long COVID include postural orthostatic tachycardia syndrome (POTS) […] Treatment of POTS has historically focused on maintaining blood pressure through salt supplementation, graded exercise, compression stockings, and medications. In general, a similar treatment approach is recommended for the management of POTS secondary to long COVID. […] Medications commonly recommended for the treatment of POTS (regardless of the etiology), such as propranolol and midodrine, may also be considered in the treatment of POTS secondary to long COVID. A growing number of studies support the use of low-dose naltrexone, which may reduce neuroinflammation contributing to dysautonomia in patients with long COVID.

• #107 Management of POTS due to Long COVID | AAFP

  https://www.aafp.org/pubs/afp/afp-community-blog/entry/management-of-pots-due-to-long-covid.html

  Forms of cardiac dysautonomia associated with long COVID include postural orthostatic tachycardia syndrome (POTS) […] Treatment of POTS has historically focused on maintaining blood pressure through salt supplementation, graded exercise, compression stockings, and medications. In general, a similar treatment approach is recommended for the management of POTS secondary to long COVID. […] Medications commonly recommended for the treatment of POTS (regardless of the etiology), such as propranolol and midodrine, may also be considered in the treatment of POTS secondary to long COVID. A growing number of studies support the use of low-dose naltrexone, which may reduce neuroinflammation contributing to dysautonomia in patients with long COVID.

• #108 Medication Overview | PoTS UK

  https://www.potsuk.org/managingpots/medication-2/

  Medication is only used after a trial of non-pharmacological (without medication) treatment such as increased fluids, salts, compression and exercise. […] At this moment there are no approved medicines for the treatment of PoTS and therefore are prescribed “off licence”. Medication needs to be optimised to control symptoms so activity levels can be increased. […] Treatments must be tailored to each patient, taking into account the cause of their PoTS, and objective evidence from investigations, as the same medicine may have a different effect on an individual. […] Fludrocortisone, midodrine, beta blocker or ivabradine tend to be used initially. […] Sometimes a combination of drugs is necessary. […] Midodrine is licenced for use in orthostatic hypotension and there should be, if possible evidence of this before its use.

• #109 Teens and POTS (Postural Orthostatic Tachycardia Syndrome) – The Dysautonomia Project

  https://thedysautonomiaproject.org/teens-and-pots-postural-orthostatic-tachycardia-syndrome/

  Top Pharmacological Dysautonomia Treatments: Fludrocortisone: Increases blood volume and blood pressure. […] Midodrine: Tightens blood vessels, increases blood pressure and prevents fainting. […] Beta-Blockers: Decrease heart rate, blood pressure and adrenaline effects. […] Pyridostigmine: Increases blood pressure and muscle strength. […] Many POTS patients find that a combination of treatments involving medications, diet and lifestyle changes, physical therapy, and even alternative treatments, can help them manage their symptoms.

• #110 Postural Orthostatic Tachycardia Syndrome (POTS): Evaluation and Management | British Journal of Medical Practitioners

  https://www.bjmp.org/content/postural-orthostatic-tachycardia-syndrome-pots-evaluation-and-management

  The goal of pharmacotherapy in the treatment of POTS is to ameliorate the symptoms of POTS and thus maintain the functional capacity. Currently no drug is US FDA approved for the treatment of POTS. All pharmacology is inherently off-label. […] Majority of the evidence for the use of different pharmacological agents in the management of POTS is based on some small randomised, observational and retrospective single center studies. In clinical practice most patients are treated with a single agent and second medication from different class with a different mechanism of action is added in case of treatment failure. Resistant cases are often treated with polypharmacy. […] Fludrocortisone, a potent mineralocorticoid resulting in sodium retention, augmented fluid volume, and sensitized peripheral alpha adrenergic receptors. The effects are more pronounced in the younger population. Starting dose is 0.1-0.2 mg daily with a maximum dose of 0.4 mg. Common side effects include electrolyte imbalance and hypertension. In a study of 11 female POTS patients, fludricortisone alone or in combination with bisoprolol was associated with improvement in symptoms. Midodrine is an alpha-1 adrenoreceptor agonist and causes both arterial and venous vasoconstriction. It is commonly used as add on therapy and with starting dose at 5 mg orally three times a day. In our clinical experience we advise patients to take their first dose of midodrine 15 minutes prior to getting out of bed. An additional 5mg dose can be used for breakthrough symptoms. Midodrine is usually well tolerated with the most common complaints being nausea, goose bumps, and scalp pruritus.

• #111 Postural Orthostatic Tachycardia Syndrome (POTS): Evaluation and Management | British Journal of Medical Practitioners

  https://www.bjmp.org/content/postural-orthostatic-tachycardia-syndrome-pots-evaluation-and-management

  The goal of pharmacotherapy in the treatment of POTS is to ameliorate the symptoms of POTS and thus maintain the functional capacity. Currently no drug is US FDA approved for the treatment of POTS. All pharmacology is inherently off-label. […] Majority of the evidence for the use of different pharmacological agents in the management of POTS is based on some small randomised, observational and retrospective single center studies. In clinical practice most patients are treated with a single agent and second medication from different class with a different mechanism of action is added in case of treatment failure. Resistant cases are often treated with polypharmacy. […] Fludrocortisone, a potent mineralocorticoid resulting in sodium retention, augmented fluid volume, and sensitized peripheral alpha adrenergic receptors. The effects are more pronounced in the younger population. Starting dose is 0.1-0.2 mg daily with a maximum dose of 0.4 mg. Common side effects include electrolyte imbalance and hypertension. In a study of 11 female POTS patients, fludricortisone alone or in combination with bisoprolol was associated with improvement in symptoms. Midodrine is an alpha-1 adrenoreceptor agonist and causes both arterial and venous vasoconstriction. It is commonly used as add on therapy and with starting dose at 5 mg orally three times a day. In our clinical experience we advise patients to take their first dose of midodrine 15 minutes prior to getting out of bed. An additional 5mg dose can be used for breakthrough symptoms. Midodrine is usually well tolerated with the most common complaints being nausea, goose bumps, and scalp pruritus.

• #112 Dysautonomia International: Postural Orthostatic Tachycardia Syndrome

  https://www.dysautonomiainternational.org/page.php?ID=30

  Postural orthostatic tachycardia syndrome (POTS) is a common autonomic nervous system disorder characterized by an excessively fast heart rate and symptoms of lightheadedness upon standing. […] Each patient is different, thus consulting with a physician who has experience in treating autonomic disorders is important. The most common treatments for POTS include increasing fluid intake to 2-3 liters per day; increasing salt consumption to 8,000 mg to 10,000 mg per day; wearing compression stockings; raising the head of the bed (to conserve blood volume); reclined exercises such as rowing, recumbent bicycling and swimming; a healthy diet; avoiding substances and situations that worsen orthostatic symptoms; and finally, the addition of medications meant to improve symptoms. […] Many different medications are used to treat POTS, such as Fludrocortisone, Beta Blockers, Midodrine, Clonidine, Pyridostigmine, Benzodiazepines, SSRIs, SNRIs, Erythropoietin and Octreotide.

• #113 Choices and Challenges With Drug Therapy in Postural Orthostatic Tachycardia Syndrome: A Systematic Review

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10259876/

  The literature on pharmacologic treatments for postural orthostatic tachycardia syndrome (POTS) is inconsistent and unstandardized. Therefore, we aimed to evaluate choices in pharmacologic treatment options for POTS and the challenges encountered in the studies. Results demonstrated that pharmacologic treatment options for POTS were effective in reducing symptoms of POTS, but most of the studies were underpowered. Several were terminated due to various reasons. Midodrine ivabradine, bisoprolol, fludrocortisone, droxidopa, desmopressin, propranolol, modafinil, methylphenidate, and melatonin have been studied with positive impact but sample sizes that were low in the range of 10-50 subjects. Therefore, we concluded the treatment options effectively improve symptoms of POTS and increase orthostatic tolerance, but more evidence is needed as most studies had a low sample size and thus are underpowered. Pharmacologic therapies have been explored in minimizing symptoms and increasing functional ability in POTS patients. Treatment targets have focused on reducing heart rate (beta-blockers), increasing cardiac output (increase in salt intake), or increasing blood pressure (midodrine). The therapies are based on the hypothesis that affecting the said parameters will reduce symptom burden and are aimed at managing symptoms such as lightheadedness, dizziness, and rapid heartbeat that occur when standing up. Patients with POTS may respond differently to therapy depending on their intensity, underlying disorders, and other medical conditions. The treatment is directed at symptom burden which may or may not include dizziness/lightheadedness, fainting, rapid heartbeat/palpitations, chest pain/discomfort, shortness of breath, headaches, fatigue/weakness, nausea, abdominal pain, brain fog/difficulty concentrating, blurred vision, sweating, shakiness/tremors, insomnia/disrupted sleep, exercise intolerance. The reduction in symptom burden may be due to the ability of pharmacologic treatments to regulate the autonomic nervous system, which controls many of the body’s involuntary functions, including heart rate, blood pressure, and digestion. By regulating the autonomic nervous system, pharmacologic treatments can help improve blood flow and reduce symptoms such as lightheadedness, dizziness, and fatigue, common in patients with POTS. Patients and doctors alike face formidable obstacles in dealing with postural tachycardia syndrome. Because POTS may profoundly influence patients’ quality of life, there is an urgent need for better treatment alternatives. Patients with POTS might expect reduced symptoms and enhanced functional ability with the help of pharmacologic therapies. However, patient-specific treatment plans that account for comorbidities, drug tolerance, and other factors are necessary. Prescribing drugs to people with POTS might further complicate care if practitioners aren’t aware of possible side effects and drug interactions. To get the best results from therapy, it’s important to include non-pharmacologic measures alongside drug therapy.

• #114 Understanding and Managing Postural Orthostatic Tachycardia Syndrome

  https://www.uspharmacist.com/article/understanding-and-managing-postural-orthostatic-tachycardia-syndrome

  Pharmacists should be aware of the various treatment approaches and monitor patients to determine optimal therapeutics. […] In the absence of a clear underlying cause, pharmacists can recommend that patients schedule an appointment with their physician to further evaluate symptoms. […] If a patient is diagnosed with POTS, the pharmacist can provide education on the disorder, including typical presentation and nonpharmacologic and pharmacologic treatment approaches.

• #115 Postural Orthostatic Tachycardia Syndrome (POTS) (for Parents) | Nemours KidsHealth

  https://kidshealth.org/en/parents/pots.html

  POTS is a chronic (long-term) problem. So doctors try to prevent and manage the things that cause it. […] Helpful treatments include: more water and salt intake, better and longer sleep, a slow increase in exercise, starting with seated, reclined, or horizontal exercises (such as rowing, recumbent bicycling, and swimming), wearing compression (squeezing) stockings, raising the head of the bed so some pressure stays in the blood vessels in the legs during sleep, psychological counseling to help manage stress and choices that trigger symptoms, sometimes, prescription medicines. […] The autonomic nervous system is involved in many body functions, so managing all the symptoms related to it can be hard. Sometimes, patients try a few different treatments to find what works well without unpleasant side effects. Multiple doctor’s visits may be needed to find the best combination of treatments that improve symptoms.

• #116 Get postural orthostatic tachycardia treatment | Cleveland Clinic

  https://my.clevelandclinic.org/services/pots-treatment

  Postural orthostatic tachycardia syndrome treatment involves therapies, education and self-care practices, like exercising. We tailor treatment recommendations to your needs. Recovery takes time. Its not uncommon for it to take six months to a year to feel better. Your treatment may include: […] Biofeedback, which uses painless sensors to measure your bodys autonomic response to treatment in real time. For example, easing muscle tension can lower your heart rate. […] Cardiac rehabilitation, which is a medically supervised exercise program that provides a safe environment for learning to exercise. […] Medications, which may control your heart rate, improve blood flow or raise blood pressure. You may also need headache medicine if your POTS symptoms include migraines. […] Talk therapy, which involves meeting with our health psychologist. These conversations help you cope with the challenges of living with POTS.

• #117 Dysautonomia and Postural Orthostatic Tachycardia Syndrome (POTS) – Conditions and Treatments | Children’s National Hospital

  https://www.childrensnational.org/get-care/health-library/dysautonomia-and-pots

  Increased salt intake either by adding table salt to your diet or, if your doctor feels its necessary, by taking over-the-counter salt supplements. Increasing salt helps the body hold onto the extra fluid you are drinking. Eating salty food, adding salt to foods or taking salt supplements may be a change in your normal eating pattern but may be an important part of the treatment in conjunction with drinking adequate water. […] Studies show that regular exercise is one of the most important treatments for POTS. Starting slowly and steadily increasing activity will gradually help you to feel better, even if you feel too tired or dont want to exercise. You should exercise 5-7 days per week. If unable to exercise on your own, sometimes we recommend physical therapy or a personal trainer. […] If the above measures do not work or dont provide enough improvement in symptoms, there are several types of medicines that can be trialed to help reduce symptoms. […] This counseling is done with a psychologist trained in the technique. CBT helps patients work to adapt to the POTS symptoms and be more functional in their daily lives. Mindfulness can also be helpful.

• #118 Postural Orthostatic Tachycardia Syndrome Symptoms & Treatment

  https://drbrighten.com/postural-orthostatic-tachycardia-syndrome/

  SSRIs (Selective Serotonin Reuptake Inhibitors): These can help balance your autonomic nervous system and support mental well-being. […] Physical therapy: Specialized exercise programs can gradually improve your ability to stand and move without triggering symptoms. […] Cognitive Behavioral Therapy (CBT): POTS can take a toll on your emotional health, such as by increasing anxiety. Therefore, therapy can help you deal with stress, process anxiety, and learn helpful coping mechanisms.

• #119 Living With POTS – Australian POTS Foundation

  https://potsfoundation.org.au/living-with-pots/

  Ivabradine: Ivabradine is another medication that can lower heart rate and improve symptoms of POTS. […] Fludrocortisone: Fludrocortisone helps increase blood volume by promoting salt and fluid retention in the body. […] Propranolol: Propranolol is a beta-blocker that can help control heart rate and reduce symptoms like palpitations and tachycardia. […] Vagus Nerve Stimulation: Techniques such as deep breathing exercises, vagus nerve stimulation, and cold-water therapy are thought to stimulate the vagus nerve, which plays a role in regulating heart rate and blood pressure.

• #120 Get postural orthostatic tachycardia treatment | Cleveland Clinic

  https://my.clevelandclinic.org/services/pots-treatment

  Postural orthostatic tachycardia syndrome treatment involves therapies, education and self-care practices, like exercising. We tailor treatment recommendations to your needs. Recovery takes time. Its not uncommon for it to take six months to a year to feel better. Your treatment may include: […] Biofeedback, which uses painless sensors to measure your bodys autonomic response to treatment in real time. For example, easing muscle tension can lower your heart rate. […] Cardiac rehabilitation, which is a medically supervised exercise program that provides a safe environment for learning to exercise. […] Medications, which may control your heart rate, improve blood flow or raise blood pressure. You may also need headache medicine if your POTS symptoms include migraines. […] Talk therapy, which involves meeting with our health psychologist. These conversations help you cope with the challenges of living with POTS.

• #121 Get postural orthostatic tachycardia treatment | Cleveland Clinic

  https://my.clevelandclinic.org/services/pots-treatment

  Thigh-high medical compression stockings, which help push blood from your legs up toward your heart. […] Shared medical appointments let you connect with other people with POTS for extra support and to learn more about POTS and recovery. Our POTS experts lead each small, private group session. These group appointments focus on topics like how to get relief from POTS, exercise recommendations and how to get the most out of treatment. […] Even though POTS isnt a life-threatening condition, it can interrupt your daily life. But theres good news there are treatment options available that can help. If youve been living with POTS, we can help. Well take the time to get to know you and learn about the symptoms youve experienced. Working together, well craft a treatment plan that helps you get back to doing the things you want to do without POTS getting in the way.

• #122 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment | Blog

  https://fullyfunctional.com/blog/postural-orthostatic-tachycardia-syndrome-pots/

  Quinton marine plasma. We prescribe this sea water source of active, ionic ocean minerals for many patients. […] Pulsed Electro-Magnetic Frequency (PEMF) treatment. This treatment is something we offer many of our POTS patients because research has proven neurological, physiological, and psychological benefits with the use of PEMF. […] Licorice Root. This herbal supplement is used short-term for adrenal support and can sometimes be used as an alternative to Florinef, a steroid often prescribed in the treatment of adrenal dysfunction and POTS. […] Wear compression devices. Pooling of blood in the lower extremities is effectively addressed using 30 mm Hg of pressure with effective stockings. […] Stress reduction. Stress exacerbates symptoms of POTS so we recommend use of daily relaxation techniques such as breathing exercises, prayer, meditation, gratitude journaling, yoga and tai chi.

• #123 POTS: Causes, Symptoms, Diagnosis & Treatment

  https://my.clevelandclinic.org/health/diseases/16560-postural-orthostatic-tachycardia-syndrome-pots

  The prognosis (outlook) for POTS is generally good, although it can severely disrupt daily living. POTS symptoms may come and go for years. In approximately 80% of cases, the condition improves, but many people have residual symptoms. […] Learning that you have postural orthostatic tachycardia syndrome (POTS) can be overwhelming. Know that there are several treatments and lifestyle adaptations that can help manage your symptoms.

• #124 POTS: Causes, Symptoms, Diagnosis & Treatment

  https://my.clevelandclinic.org/health/diseases/16560-postural-orthostatic-tachycardia-syndrome-pots

  The prognosis (outlook) for POTS is generally good, although it can severely disrupt daily living. POTS symptoms may come and go for years. In approximately 80% of cases, the condition improves, but many people have residual symptoms. […] Learning that you have postural orthostatic tachycardia syndrome (POTS) can be overwhelming. Know that there are several treatments and lifestyle adaptations that can help manage your symptoms.

• #125 Is There a Cure for POTS and How Can Symptoms Be Managed Effectively? – Mayo Clinic News Network

  https://newsnetwork.mayoclinic.org/discussion/though-no-cure-for-pots-symptoms-can-often-be-effectively-managed/

  A cure for POTS doesn’t exist at this time. Fortunately, teenagers — a group commonly affected by POTS — usually grow out of the disorder by the time they reach their early 20s. In the meantime, POTS symptoms can often be

• #126 Teens and POTS (Postural Orthostatic Tachycardia Syndrome) – The Dysautonomia Project

  https://thedysautonomiaproject.org/teens-and-pots-postural-orthostatic-tachycardia-syndrome/

  POTS falls under the umbrella of dysautonomia. […] Although theres no known cure for POTS, a multi-faceted approach to treatment means rehabilitation and recovery is possible for many teens. […] There is no cure, but the symptoms can be treated. In fact, there is good news for teens. Rehabilitation and treatment can help them regain their daily activities and lives. In addition, many teens find their symptoms resolve by the time the age of 20. […] Treatment starts by finding a provider who understands or is willing to learn about and treat POTS. A family-based approach to treatment and support of the patient is most effective. However, its important for the teen patient to engage and take ownership of their healthcare at an age-appropriate level. […] Here are a few of the top pharmacological and non-pharmacological treatments. All treatment should be done under the care of a provider, include:

• #127 Postural Orthostatic Tachycardia Syndrome (POTS) – Child Neurology Foundation

  https://www.childneurologyfoundation.org/disorder/postural-orthostatic-tachycardia-syndrome-pots/

  Medications. These include, but are not limited to: […] Corticosteroids. These help the body retain salt. One example is fludrocortisone. […] Vasoconstrictors. These increase blood pressure. One example is midodrine […] Beta blockers. These stabilize blood pressure. Examples are metoprolol and propranolol. […] Most people with POTS have some recovery within 1 to 5 years of using first-line treatments. However, some symptoms may not resolve. Adolescents with POTS may have recurrences later in life.

• #128 Postural Orthostatic Tachycardia Syndrome

  https://practicalneurology.com/articles/2020-mar-apr/postural-orthostatic-tachycardia-syndrome

  Nonpharmacologic treatment with fluids, salt, and exercise are recommended as first-line therapy for POTS. The use of medications can be considered with the knowledge that evidence for their use is suboptimal. Although POTS should be considered a chronic disorder, appropriate multimodal treatment can improve and potentially resolve symptoms.

• #129 POTS-associated Conditions and Management Strategies | USC Journal

  https://www.uscjournal.com/articles/narrative-review-postural-orthostatic-tachycardia-syndrome-associated-conditions-and?language_content_entity=en

  Postural orthostatic tachycardia syndrome (POTS) is a heterogeneous disorder that presents with positional tachycardia and a constellation of other symptoms. Peer-reviewed evidence for treatment options is limited. […] Treatment regimens are extremely patient specific and primarily focus on symptom improvement and gradual exercise tolerance. […] There are various therapies available for the management of POTS. Although some of these therapies are recommended based on peer-reviewed evidence, there are additional medications that have been anecdotally found to be effective. […] Special care should also be taken to not only treat POTS symptoms, but also to treat the potential underlying cause or associated condition the patient presents with. […] Non-pharmacologic Therapies […] Exercise, increased salt (10-12 g/day) and fluid intake (2-3 l/day), and discontinuing medications that may contribute to POTS should be initiated in all patients diagnosed with POTS.

• #130 Postural Orthostatic Tachycardia Syndrome – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK541074/

  Postural orthostatic tachycardia syndrome is a condition where an unusually significant increase in heart rate accompanies the action of an individual going from lying to standing. […] Describe the treatment modalities indicated for postural orthostatic tachycardia syndrome. […] The management of postural orthostatic tachycardia syndrome is divided into non-pharmacologic and pharmacologic approaches and is contingent on accurate diagnosis, patient education, and therapy adherence. […] Patient education and management of expectations are crucial to the overall successful management of POTS, given its often non-specific and chronic debilitating nature. […] Exercise conditioning is a fundamental aspect of postural orthostatic tachycardia syndrome treatment (class IIA), and it is a recommendation for all patients to start on a gradual physical exercise regimen.

• #131 POTS: Causes, Symptoms, Diagnosis & Treatment

  https://my.clevelandclinic.org/health/diseases/16560-postural-orthostatic-tachycardia-syndrome-pots

  Managing diet and nutrition is another important aspect of managing POTS symptoms. […] If you have the hypovolemic (low blood volume) form of POTS, your healthcare provider will likely recommend increasing both your fluid and salt intake to increase blood volume. […] The U.S. Food and Drug Administration (FDA) hasnt approved any medications for POTS treatment. But healthcare providers sometimes prescribe medications off-label to help certain POTS symptoms. […] These medications include: Fludrocortisone (increases salt retention and blood volume). Pyridostigmine (may reduce tachycardia). Midodrine (causes widespread vasoconstriction). Beta-blockers (may reduce upright tachycardia). […] Aside from exercise and dietary changes, other things you can do to manage POTS include frequently monitoring your pulse and blood pressure and getting quality sleep.

• #132 POTS-associated Conditions and Management Strategies | USC Journal

  https://www.uscjournal.com/articles/narrative-review-postural-orthostatic-tachycardia-syndrome-associated-conditions-and?language_content_entity=en

  Ivabradine, a drug approved by the FDA for symptomatic heart failure with reduced ejection fraction, is being increasingly used in POTS patients due to its cardiac selectivity. […] Pyridostigmine acts to inhibit acetylcholinesterase, increasing the availability of acetylcholine at ganglionic nicotinic receptors and postganglionic muscarinic receptors. […] Medications That Target Hypovolemia […] In addition to salt supplementation, fludrocortisone, a glucocorticoid that acts similarly to aldosterone, has shown efficacy in improving POTS symptoms. […] Therapies directed towards mast cell activation may also provide benefit in patients with POTS, particularly those with suspected coexisting MCAS. […] For patients with autoimmune-associated POTS, particularly those diagnosed with SFN, IVIG and plasmapheresis have demonstrated improvement in symptoms.

• #133 Dysautonomia International: Postural Orthostatic Tachycardia Syndrome

  http://www.dysautonomiainternational.org/page.php?ID=30

  Currently, there is no cure for POTS, however researchers believe that some patients will see an improvement in symptoms over time. Detailed long term follow up studies on the course of POTS are sparse, but Dysautonomia International is working with researchers to begin to collect long term follow up data. With proper lifestyle adjustments, exercise, diet and medical treatments, many patients see an improvement in their quality of life. If an underlying cause can be identified, and if that cause is treatable, the POTS symptoms may subside. While the prognosis is good for most patients, researchers have noted that some patients will not improve and may actually worsen over time.

• #134 POTS: Causes, Symptoms, Diagnosis & Treatment

  https://my.clevelandclinic.org/health/diseases/16560-postural-orthostatic-tachycardia-syndrome-pots

  The prognosis (outlook) for POTS is generally good, although it can severely disrupt daily living. POTS symptoms may come and go for years. In approximately 80% of cases, the condition improves, but many people have residual symptoms. […] Learning that you have postural orthostatic tachycardia syndrome (POTS) can be overwhelming. Know that there are several treatments and lifestyle adaptations that can help manage your symptoms.

Zobacz więcej